Document:

QuickLinks
 -- Click here to rapidly navigate through this document
  

 
 

Exhibit 10.24    
    

 
  LICENSE TRANSFER AND TRANSITION SERVICES AGREEMENT    
    

        THIS LICENSE TRANSFER AND TRANSITION SERVICES AGREEMENT (this "Agreement") is made and entered into this
30th day of January 2004, by and among Refocus Group, Inc., a Delaware corporation and formerly known as VeryBestoftheInternet.com, Inc., with its principal office
located at 10300 North Central Expressway, Suite 104, Dallas, Texas USA 75231 ("Refocus"), Refocus Ocular, Inc., a Delaware corporation,
wholly-owned subsidiary of Refocus and formerly known as Presby Corp, with its principal office located at 10300 North Central Expressway, Suite 104, Dallas, Texas USA 75231
("Licensor"), CIBA Vision AG, a Swiss corporation, whose principal address is Hardhofstrasse 15, CH-8424, Embrach, Switzerland
("Licensee"), and CIBA Vision Corporation, a Delaware corporation, whose principal address is 11460 Johns Creek Parkway, Duluth, Georgia USA 30097
("CIBA"). All initially capitalized terms not defined herein shall have the meanings attributable to them in the License Agreement (as defined herein). 

RECITALS  

        WHEREAS, Licensor and Licensee are parties to that certain License Agreement, dated March 6, 2002, as amended by that certain Letter Agreement, dated
March 3, 2003, and that certain Second Amended & Restated Term Sheet, dated February 3, 2003 (collectively, the "License
Agreement"), pursuant to which Licensor granted to Licensee, among other things, the right to utilize Licensor's patent rights and other intellectual property rights in
connection with the manufacture, marketing and sale of certain ophthalmic medical devices used in the treatment of presbyopia, hyperopia, ocular hypertension and glaucoma; and 

        WHEREAS,
Licensor and Licensee wish to terminate the License Agreement, transfer the rights of Licensee under the License Agreement to Licensor and release each other of their respective
obligations under the License Agreement, and Licensor has requested, and CIBA has agreed to, provide certain transitional services to Licensor, upon and subject to the terms and conditions of this
Agreement. 

AGREEMENT  

        NOW THEREFORE, in consideration of the mutual covenants and conditions contained herein and other good and valuable consideration, the receipt and sufficiency of
which are hereby acknowledged by the execution and delivery hereof, the parties, intending to be legally bound hereby, hereby agree as follows: 

A.    Mutual Termination and Transfer of License Agreement.    

        1.     Licensor
and Licensee hereby agree that effective on January 30, 2004 (the "Effective Date"), the License Agreement
and all rights and obligations of the parties thereto shall terminate and be of no further force or effect, except as provided in this Agreement. All rights granted to Licensee under and pursuant to
the License Agreement, including, without limitation, the Patent Rights, Know How and Trademarks, shall revert to Licensor on the Effective Date. Licensee and CIBA hereby agree and acknowledge that
any and all royalties paid by Licensee, CIBA or their respective affiliates to Licensor, whether prepaid or earned, prior to the Effective Date shall be deemed forgiven by Licensor, and Licensee, CIBA
and their respective affiliates shall have no right, title and interest in and to any and all of the royalty payments made by them to Licensor prior to the Effective Date. 

        2.     Licensee
hereby grants, transfers, conveys and assigns, and shall cause CIBA and CIBA's and Licensee's affiliates to grant, transfer, convey and assign, all of
Licensee's, CIBA's and their respective affiliates' right, title and interest in and to any and all improvements, modifications, alterations and additions to, and any other inventions related directly
to, the Products to Licensor. Licensee, CIBA and 

1

 

their
respective affiliates shall pay all reasonable expenses, costs and applicable taxes, including, but not limited to, reasonable attorneys' fees, required to effectuate the transfer to Licensor as
contemplated by the foregoing sentence. 

        3.     Except
as may be required in connection with the services to be performed by Licensee, CIBA and their respective affiliates hereunder, not later than February 6,
2004, Licensor, CIBA and their respective affiliates shall have granted, transferred, conveyed and assigned, or caused to be granted, transferred, conveyed and assigned, all of Licensee's, CIBA's and
their respective affiliates' right, title and interest in and to any and all patents and marks, whether issued or pending, relating to the Products and the manufacture, marketing and sale of the
Products, including, without limitation, those marks listed on Exhibit A attached hereto, to Licensor. Upon completion of the services to be
rendered by Licensee, CIBA and their respective affiliates under this Agreement, Licensor, CIBA and their respective affiliates shall grant, transfer, convey and assign, or caused to be granted,
transferred, conveyed and assigned, all of Licensee's, CIBA's and their respective affiliates' right, title and interest in and to any and all patents and marks, whether issued or pending, relating to
the Products and the manufacture, marketing and sale of the Products, including, without limitation, those marks listed on Exhibit A attached
hereto, to Licensor that were not previously granted, transferred, conveyed and assigned to Licensor pursuant to this Section A.3. All patents
and marks so granted, transferred, conveyed and assigned to Licensor pursuant to this Agreement shall be effected pursuant an Assignment Agreement, substantially in the form attached hereto as  Exhibit B. Licensor shall pay all reasonable expenses, including, but not limited to, reasonable attorneys' fees, required to effectuate the
transfers contemplated by this Section A.3. 

        4.     Except
as may be required in connection with the services to be provided by Licensee, CIBA and their respective affiliates hereunder, Licensee, CIBA and their respective
affiliates shall, upon Licensor's written request and at Licensor's expense, deliver, transfer, convey, assign and return to Licensor or its designee all Products and all information, materials,
equipment and documentation, including, but not limited to, all regulatory, design control, manufacturing, labeling, marketing and site audit documentation, clinical protocols, data and records,
relating to the Products and Licensor or its affiliates and predecessors in Licensee's, CIBA's or their respective affiliates possession, whether prepared, created, developed or manufactured by
Licensee, CIBA or their respective affiliates, agents or representatives (collectively, the "Records"). Upon completion of the services to be rendered
by Licensee, CIBA and their respective affiliates under this Agreement, Licensor, CIBA and their respective affiliates shall deliver, transfer, convey, assign and return to Licensor or its designee,
at Licensor's expense, all Products and Records in Licensee's, CIBA's or their respective affiliates possession that were not previously delivered, transferred, conveyed, assigned and returned to
Licensor pursuant to this Section A.4. Notwithstanding anything to the contrary contained in this  Section A.4, Licensee, CIBA and their
respective affiliates shall be entitled to retain copies of such Records for archival purposes and to the
extent it is required to do so by law. 

        5.     All
warrants to purchase Refocus common stock issued to Licensee, CIBA or their respective affiliates in connection with the private placement and merger consummated by
Licensor, Refocus and their respective affiliates on March 6, 2003 (the "Warrants"), shall be cancelled and be of no further force or effect.
Licensee and CIBA have made, or have caused to be made, a search for the agreements evidencing the Warrants and have been unable to find or recover such agreements. Licensee, CIBA and their respective
affiliates hereby represent that: (i) their interests in the Warrants has not been sold, assigned, endorsed, transferred, deposited under any agreement, hypothecated, pawned, pledged for any
loan or disposed of in any manner, (ii) they have not executed, or entered into, any power of attorney, any stock power or any other assignment or authorization with respect to the Warrants,
and (iii) no other person or entity has any right, title, claim, equity or interest in, to or respecting the Warrants. Licensee, CIBA and their respective affiliates hereby agree that if any 

2

 

agreement
evidencing any portion or all of the Warrants comes into any of their custody or control, they will deliver such agreements to Refocus. 

B.    Lock-Up Provisions and Standstill.    

        1.     Licensee,
CIBA and their respective affiliates shall not publicly sell, contract to sell or otherwise dispose of (a
"Transfer") any securities of Refocus beneficially owned them on the Effective Date; provided, however, that following the earlier of (i) six
(6) months after the effective date of a registration statement covering the resale of the Refocus securities beneficially owned by Licensee, CIBA and their respective affiliates on the
Effective Date, or (ii) September 6, 2004, Licensee, CIBA and their respective affiliates may Transfer per month that maximum number of shares of Refocus common stock equal to nine
percent (9%) of the aggregate number (the "Base Number") of shares of Refocus common stock beneficially owned by Licensee, CIBA and their respective
affiliates on the Effective Date, subject to applicable securities laws. In no case shall Licensee, CIBA and their respective Transfer in any given month more than nine percent (9%) of the Base
Number. 

        2.     Licensee,
CIBA and their respective affiliates hereby agree and acknowledge that the stock certificates evidencing the shares of Refocus common stock beneficially owned
by Licensee, CIBA and their respective affiliates on the Effective Date shall bear a legend relating to the provisions of this Section B. 

        3.     Licensee,
CIBA and their respective affiliates hereby agree that, for a period of two (2) years from the date of this Agreement, unless they shall have been
specifically invited in writing by the Board of Directors of Refocus, neither Licensee, CIBA nor their respective affiliates shall in any manner, (i) acquire, agree to acquire or make any offer
or proposal to acquire, directly or indirectly, common stock or other securities of Refocus, Licensor or any of their respective subsidiaries (or beneficial ownership thereof) or any assets of
Refocus, Licensor or any of their respective subsidiaries; (ii) make, or in any way participate, directly or indirectly, in any "solicitation" of "proxies" (as such terms are used in the proxy
rules promulgated by the Securities and Exchange Commission) to vote, or seek to advise or influence any person with respect to the voting of any voting securities of Refocus, Licensor or any of their
respective subsidiaries; (iii) effect, or seek to effect, or cause any merger or other business combination involving Refocus, Licensor or any of their respective subsidiaries or any
recapitalization, restructuring, liquidation, dissolution or other extraordinary transaction with respect to Refocus, Licensor or any of their respective subsidiaries; (iv) form, join or in any
way participate in a "group" (within the meaning of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended) with respect to any voting securities of Refocus, Licensor or any of
their respective subsidiaries; (v) otherwise act, alone or in concert with others, to seek to control the management, Board of Directors or policies of Refocus, Licensor or any of their
respective subsidiaries; (vi) disclose any intention, plan or arrangement inconsistent with the foregoing; or (vii) advise, assist, aid or abet or encourage any persons in connection
with any of the foregoing. 

C.    Transition Services.    During the Term (as defined herein), Licensor, CIBA and their respective affiliates shall perform and
complete, or be responsible for the performance and completion of, the tasks and services set forth in Exhibit C attached hereto (collectively,
the "Services"). The Services shall be performed and completed in a timely and diligent manner consistent with the periods for completion to be mutually
agreed to by Licensor, CIBA and Licensee; provided, however, Licensee and CIBA shall not be responsible
for any delays caused by Licensor, any third-parties retained by Licensor or performance issues related to the Products. The Services shall be performed in accordance with the requirements set forth
or reasonably inferable from this Agreement. The Services shall be performed in good faith and in accordance with all applicable codes, ordinances and other requirements of governmental or regulatory
authorities having jurisdiction over the services and work being performed. For purposes of this Agreement, "Term" shall mean the Effective Date until December 31, 2004. 

3

 

D.    Consideration and Cost Allocation.    

        1.     As
compensation for the termination of License Agreement, the forgiveness of any and all royalties paid under the License Agreement, and the services to be performed
under this Agreement by Licensee, CIBA and their respective affiliates, and in consideration for the other promises and covenants of Licensee, CIBA and their respective affiliates, Licensor shall pay
to CIBA, in lawful money of the United States of America, an aggregate of $3,000,000. The payment of such amount to CIBA by Licensor shall be due and payable in twelve (12) equal consecutive
quarterly installments on the last day of each calendar quarter until paid in full, commencing on March 31, 2006; provided,  however, that Licensor
shall have the right to prepay such amount, and if Licensor shall pay to CIBA, in lawful money of the United States of America,
an aggregate of $2,000,000 prior to January 1, 2006, such payment shall constitute full and final payment of the aggregate amount to be paid to CIBA by Licensor pursuant to this  Section D.

        2.     Licensee,
CIBA and their respective affiliates shall be responsible and pay for any and all costs associated with Licensee's, CIBA's and their respective affiliates'
employees prior to and during the Term. Additionally, Licensee, CIBA and their respective affiliates shall be responsible and pay for any and all and services rendered by third-parties and any and all
materials and equipment relating to, and used in connection with, the Products that were purchased and delivered on or prior to December 31, 2003;  provided, however, Licensor shall be responsible and pay for the equipment purchased, or to be
purchased, from Wavefront Sciences, Inc., and Licensee, CIBA and their respective affiliates shall be responsible and pay for an aggregate of $21,000 of modifications to such equipment
purchased, or to be purchased, by Licensor from Wavefront Services, Inc. 

        3.     Licensor
and Refocus shall be responsible and pay for any and all costs associated with their respective employees. Additionally, Licensor shall be responsible for the
selection, retention and compensation of suppliers, medical monitors, clinical investigators, consultants and other third-party service providers (other than Licensee, CIBA and their respective
affiliates), and shall be responsible for any and all additional materials and equipment required to be used in connection with the development, manufacture, marketing and sale of the Products, after
December 31, 2003, except as specifically set forth in Section D.2 above. 

E.    Additional Covenants; Representations and Warranties.    

        1.     Not
later than February 6, 2004, Licensee, CIBA and their respective affiliates shall transmit a letter, in substantially the form attached hereto as  Exhibit D, to each party listed on
Exhibit E attached hereto, informing such party of the
termination of the License Agreement. Licensee, CIBA or their respective affiliates shall provide Licensor with copies of such letters not later than 30 days after their transmittal. 

        2.     Except
as may be required in connection with the services to be performed by Licensee, CIBA and their respective affiliates hereunder, commencing on the Effective Date
and continuing thereafter, Licensee, CIBA and their respective affiliates shall cease to use any of the Products, Patent Rights, Know How and Trademarks, including, without limitation, the PresVIEW
trademark. Licensee, CIBA and their respective affiliates hereby agree that any unauthorized use or continued use of such after the Effective Date shall constitute irreparable harm subject to legal
and injunctive relief. 

        3.     Licensee,
CIBA and their respective affiliates shall, at all times, preserve in confidence any and all information furnished to Licensee, CIBA and their respective
affiliates by Licensor, Refocus and their respective affiliates on a confidential basis, and shall not disclose or otherwise disseminate such information to any individual or entity without Licensor's
prior written consent, except as may be required by law. The Secrecy Agreement, dated as of August 21, 2001, by and between RAS Holding Corp. and CIBA Vision Corporation, as amended by the
License Agreement (collectively, the "Secrecy  

4

 

 Agreement"), shall remain in full force and effect until the payment in full of the consideration set forth in  Section D.1 hereof. 

        4.     The
parties shall not issue any press release or other public statement, whether oral or written, relating to this Agreement without the prior written consent of the
other parties, which consent shall not be unreasonably withheld; provided, however, the parties shall be permitted to make such disclosures as are
required by law, rule, regulation or court order, without consent, provided that the party making such disclosure shall notify the other parties of the necessity of such disclosure and provide the
other parties with an opportunity to review any such disclosure. 

        5.     Licensee,
CIBA and their respective affiliates hereby agree and acknowledge that the Patents, Know How and Trademarks are owned by Licensor. Licensee, CIBA and their
respective affiliates shall not, directly or indirectly, contest or aid in contesting the validity or ownership of the Patents or Trademarks, nor shall Licensee, CIBA and their respective affiliates
act in any manner injurious or prejudicial to the Patents or Trademarks or Licensor's interest or rights therein. 

        6.     Except
as specifically set forth herein, Licensor and Licensee do hereby release and forever discharge each other and their respective successors, affiliates,
shareholders, representatives, assigns, agents, employees, officers and directors ("Designees") of and from any claims, debts, liabilities, demands,
obligations, costs, expenses, actions and causes of action of every nature, character and description, known or unknown, vested or contingent, which either now owns or holds, or has at any time
heretofore owned or held, or may at any time own or hold against the other or its Designees, arising prior to and including the Effective Date, including, without limitation, any such claims that
Licensor, Licensee or their respective Designees may have (1) arising under the License Agreement or other related agreement between Licensee or Licensor or their respective Designees, other
than the Secrecy Agreement, (2) arising from the parties' conduct during the term of the License Agreement, (3) relating to compensation payable to directors of Refocus, Licensor or
their respective affiliates, or (4) arising under any federal, state and local laws, rules or ordinances; provided,  however, that this release shall
exclude claims arising from the assertion or enforcement of any continuing rights or obligations set forth in this
Agreement, the Secrecy Agreement and any other agreement contemplated herein. 

        7.     By
executing this Agreement, Licensor, Refocus, Licensee and CIBA, for themselves and their respective Designees, represent and warrant that each of them has the right
and authority to enter into and accept the terms and covenants of this Agreement, and that no third party has or claims an interest in any claim released by this Agreement. 

        8.     Licensor,
Refocus, Licensee and CIBA, for themselves and their respective Designees, acknowledge that this Agreement shall be a complete defense to any claim that is
subject to the terms hereof, consent to the entry of a temporary or permanent injunction, whether affirmative or negative, to prevent or end any breach hereof; and agree to indemnify each other and
their respective Designees for any and all costs and expenses incurred as a result of a breach of this Agreement, including reasonable attorneys' fees. 

        9.     Each
party hereto shall pay to the other party all damages, costs and expenses, including reasonable attorneys' fees, incurred by the other party subsequent to the date
of this Agreement in obtaining injunctive or other relief for the enforcement of any provision of this Agreement. 

        10.   Each
of the parties hereto hereby represents and warrants that its execution and delivery of this Agreement does not violate any other agreement to which it is a party. 

        11.   Licensor,
Refocus, Licensee, CIBA and their respective affiliates hereby agree to cooperate in good faith and direct their respective employees to assist, and work with,
the representatives of the other and to provide such information and other assistance as may be reasonably necessary to fulfill the purposes and intent of this Agreement. 

5

 

        12.   During
the Term, Licensee, CIBA and their respective affiliates hereby agree to provide Licensor, Refocus and their respective employees and representatives, upon
reasonable prior notice to Licensee, CIBA and their respective affiliates, as applicable, by Licensor, reasonable access to Licensee's, CIBA's and their respective affiliates' facilities, personnel
and all Records during normal business hours. To extent made know or provided to Licensor, Licensor and Refocus agree, and agree to cause their respective employees and representatives, to observe all
rules, policies and procedures applicable to employees of Licensee, CIBA and their respective affiliates at such premises while on such premises. 

        13.   Licensor,
Refocus, Licensee, CIBA and their respective affiliates hereby agree to work cooperatively to complete all requirements to commence the marketing and sale of
the Products in the European Union in accordance with Medical Device Directive 93/42 EEC (the "MDD"). Subject to the completion of such
requirements, Licensee, CIBA and their respective affiliates shall grant Licensor the right to distribute, market and sell the Products under Licensee's, CIBA's or their respective affiliates' CE Mark
during the remainder of the Term. Not later than February 27, 2004, Licensor, Licensee, CIBA and their respective affiliates hereby agree to enter into a technical agreement and any other
necessary agreements, each upon such mutually agreeable and reasonable terms and conditions as may be required, in order to permit the distribution, marketing and sale of the Products by Licensor,
Refocus and their respective affiliates utilizing Licensee's, CIBA's or their respective affiliates' CE Mark; provided, however, under such technical
agreement and any other agreement: (i) Licensor, Refocus or their respective affiliates shall have the exclusive right, as a distributor agent, to market, distribute and sell the Products
utilizing Licensee's, CIBA's or their respective affiliates' CE Mark for the remainder of the Term; (ii) Licensor's, Refocus' and their respective affiliates' costs shall be limited only to the
reimbursement of reasonable out-of-pocket costs for third-party fees and expenses incurred by Licensee, CIBA and their respective affiliates; (iii) Licensor, Refocus and
their respective affiliates shall be entitled to market the Products utilizing packaging that contains marks of Licensee, CIBA and/or their respective affiliates, and use the names of Licensee, CIBA
and their respective affiliates, when necessary or required (excluding the use of such names for promotional purposes), for the remainder of the Term; (iv) Licensor, Refocus and their
respective affiliates shall be responsible for all supply, manufacturing and physical distribution decisions involving the Products, whether executed through Licensee, CIBA or their respective
affiliates or directly as a distributor agent of Licensee, CIBA or their respective affiliates, during the Term; (v) Licensee, CIBA and their respective affiliates shall also during the Term:
(a) maintain a Quality System approval for their respective facilities according to the relevant Annex of the Medical Device Directive and inform Licensor of any changes thereto, (b) be
responsible for the development and maintenance of all technical documentation relating to the Products and provide Licensor, upon its request, with copies of such documentation, (c) be
responsible for, in consultation with Licensor, reporting any adverse incident relating to the Products to the relevant Competent Authority in accordance with Medical Device Vigilance System
Guidelines and provide copies of the final reports submitted to such authority to Licensor, and (d) have the regulatory responsibility for the design, manufacture, packaging and labeling of the
Products as required by the MDD; and (vi) Licensor, Refocus, Licensee, CIBA and their respective affiliates shall work cooperatively and in good faith to plan and execute an uninterrupted
transfer of the CE Mark responsibilities from Licensee, CIBA or their respective affiliates to Licensor, Refocus or their respective affiliates during the Term, including, without limitation, the
timely transfer of all files, documents, certifications, filings and related materials and the holding of meetings, as reasonably necessary and appropriate, among the parties to effect the transfer of
such responsibilities. For purposes of this Section E.13 only, the terms "Licensor, Refocus and/or their respective affiliates" shall include,
without limitation, any assignee, designee, agent, representative, sub-distributor, subcontractor or independent contractor of Licensor, Refocus or their respective affiliates. For
purposes of items (i) through (vi) above, the obligations of CIBA and their respective affiliates shall apply only to the Products for which CIBA or one its affiliates holds the CE Mark. 

6

 

        14.   In
performing this Agreement and the services contemplated hereunder, Licensee, CIBA and their respective affiliates shall be an independent contractor. Licensee's,
CIBA's and their respective affiliates' employees, agents and representatives shall all times identify themselves as an independent consultant for Licensor and shall not hold themselves out as an
officer, director or employee of Licensor, Refocus or their respective affiliates. Licensor, Refocus and their respective affiliates shall not be responsible for withholding, collection or payment of
income taxes or for other taxes of any nature on behalf of Licensee, CIBA or their respective affiliates or any employee, agent or representative of Licensee, CIBA or their respective affiliates.
Nothing contained in this Agreement shall make Licensee, CIBA and their respective affiliates or their employees, agents or representatives the agent, employee, joint venturer or partner of Licensor,
Refocus or their respective affiliates or provide them with the power or authority to bind Licensor, Refocus or their respective affiliates to any contract, agreement or arrangement with any
individual or entity, except with the prior written approval of the President of Licensor. 

F.    Miscellaneous.    

        1.     This
Agreement, the Secrecy Agreement and any other agreement contemplated herein, and the exhibits attached hereto, constitute the entire agreement between the parties
pertaining to the subject matter hereof, and supersede all prior and contemporaneous agreements, understandings, negotiations and discussions of the parties, whether oral or written, and there are no
warranties, representations or other agreements between the parties in connection with the subject matter hereof, except as specifically set forth herein. This Agreement may only be amended or
modified by an instrument in writing executed by Licensor, Refocus, Licensee and CIBA. No waiver of any of the provisions of this Agreement shall be deemed or shall constitute a waiver of any other
provision of this Agreement, whether or not similar, nor shall such waiver constitute a continuing waiver unless otherwise expressly provided. 

        2.     Whenever
possible, each provision of this Agreement shall be interpreted in such manner as to be effective and valid under applicable law, but if any provision of this
Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such invalidity, illegality or unenforceability shall not affect any
other provision or any other jurisdiction, but this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or unenforceable provisions had never been
contained herein. 

        3.     All
communications, notices and disclosures required or permitted by this Agreement shall be in writing and shall be deemed to have been given at the earlier of the time
when actually delivered to an officer of the party to which notice is to be given or when sent by facsimile transmission, reputable overnight courier service or by certified or registered first-class
mail, postage prepaid, return receipt 

7

 

requested,
addressed as follows, unless and until any party notifies the others in accordance with this Section F.3. of a change of address: 

	To Refocus:	 	Refocus Group, Inc.

10300 North Central Expressway

Suite 104

Dallas, Texas USA 75231

Facsimile: (214) 368-0332

Attn: President
	

To Licensor:	
 	

Refocus Ocular, Inc.

10300 North Central Expressway

Suite 104

Dallas, Texas USA 75231

Facsimile: (214) 368-0332

Attn: President
	

To Licensee:	
 	

CIBA Vision AG

11460 Johns Creek Parkway

Duluth, Georgia USA 30097-1556

Facsimile:

Attn: General Counsel
	

To CIBA:	
 	

CIBA Vision Corporation

11460 Johns Creek Parkway

Duluth, Georgia USA 30097-1556

Facsimile:

Attn: General Counsel

        4.     The
headings of the paragraphs of this Agreement are for convenience of reference only and are not to be considered and construed in this Agreement. When the context so
requires in this Agreement, the masculine gender includes the feminine and neuter, and the singular number includes the plural, and vice versa. 

        5.     This
Agreement shall be construed and interpreted according to the laws of the State of Texas, without regard to the conflicts of laws provisions thereof. 

        6.     Neither
party may assign any of its rights or delegate any of its duties under this Agreement without the written consent of the other parties. 

        7.     This
Agreement may be executed in several counterparts, each of which shall be deemed an original, but all such counterparts shall together constitute one and the same
Agreement. 

        8.     Upon
and subject to the conditions contained herein, each of the parties hereto agrees, both before and after the Effective Date, (a) to use all reasonable efforts
to take, or cause to be taken, all actions and to do, or cause to be done, all things necessary, proper or advisable to perform the terms and intent of this Agreement, (b) to execute any
documents, agreements, instruments or conveyances of every kind that may be reasonably necessary or advisable to carry out any of the terms or the intent of this Agreement, and (c) to cooperate
with each other in connection with the foregoing, including using their reasonable efforts (i) to obtain all consents from other parties required to permit the performance of this Agreement;  provided, however, that neither Licensor, Refocus, Licensee, CIBA nor their respective affiliates shall
be required to make any payments (except as contemplated herein), commence litigation or agree to any modification of the terms thereof in order to obtain such consents, (ii) to obtain all
necessary consents as are required to be obtained under any law to permit the performance of this Agreement, (iii) to defend all litigation challenging this Agreement or performance 

8

 

of
the actions contemplated hereby, (iv) to lift or rescind any injunction or restraining order or other order adversely affecting the ability of the parties to perform their obligations
contemplated herein, (v) to effect all necessary registrations and filings and (vi) to fulfill all conditions to this Agreement. 

        9.     This
Agreement shall inure to the benefit of and be binding upon the parties and their respective successors and assigns. Whenever a reference to any party is made
herein, such reference shall be deemed to include a reference to the assigns of such party, as applicable. 

SIGNATURE PAGE FOLLOWS

9

 

        IN
WITNESS WHEREOF, the parties hereto have duly executed, sealed and delivered this Agreement, formed by twelve (12) pages and five (5) Exhibits, on the day and year first
above written. 

	REFOCUS:	 	REFOCUS GROUP, INC.
	

 	
 	

By:	
 	

 
	 	 	 	 	

	 	 	Name:	 	Terence A. Walts
	 	 	Title:	 	President and Chief Executive Officer
	

LICENSOR:	
 	

REFOCUS OCULAR, INC.
	

 	
 	

By:	
 	

 
	 	 	 	 	

	 	 	Name:	 	Terence A. Walts
	 	 	Title:	 	 
	

LICENSEE:	
 	

CIBA VISION AG
	

 	
 	

By:	
 	

 
	 	 	 	 	

	 	 	Name:	 	 
	 	 	Title:	 	 
	

CIBA:	
 	

CIBA VISION CORPORATION
	

 	
 	

By:	
 	

 
	 	 	 	 	

	 	 	Name:	 	 
	 	 	Title:	 	 

10

   EXHIBIT A  

 NON-EXCLUSIVE LIST OF MARKS  

	BU
 
	 	trademark
	 	country
	 	class(es)
	 	fil.date
	 	fil.nr.
	 	reg.date
	 	reg.nr.
	 	status

	CIBA VISION SURGICAL	 	PRESVIEW	 	AUSTRALIA	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	BENELUX	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	BRAZIL	 	10	 	24/01/2003	 	825201462	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	CANADA	 	 	 	21/01/2003	 	1165423	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	CTM	 	10	 	20/01/2003	 	30156'9	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	ESTONIA	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	FRANCE	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	INTERNATIONAL	 	10	 	21/01/2003	 	796676	 	21/01/2003	 	796676	 	Next formality 21-JAN-08
	CIBA VISION SURGICAL	 	PRESVIEW	 	JAPAN	 	10	 	21/01/2003	 	796676	 	21/01/2003	 	796676	 	Next formality 21-JAN-06
	CIBA VISION SURGICAL	 	PRESVIEW	 	LATVIA	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	LITHUANIA	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	MEXICO	 	10	 	21/01/2003	 	584510	 	27/02/2003	 	781331	 	Next formality 27-FEB-06
	CIBA VISION SURGICAL	 	PRESVIEW	 	NEW ZEALAND	 	10	 	22/01/2003	 	672216	 	24/07/2003	 	672216	 	Next formality 22-JAN-10
	CIBA VISION SURGICAL	 	PRESVIEW	 	NORWAY	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	RUSSIAN FED.	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	SINGAPORE	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	SOUTH AFRICA	 	10	 	20/01/2003	 	2003/859	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	SOUTH KOREA	 	10	 	20/01/2003	 	2003/2603	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	SWITZERLAND	 	10	 	14/01/2003	 	180/2003	 	21/01/2003	 	506619	 	Next formality 21-JAN-08
	CIBA VISION SURGICAL	 	PRESVIEW	 	THAILAND	 	10	 	24/01/2003	 	509339	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	U.S.A.	 	10	 	21/01/2003	 	78/205322	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW (KATAKANA)	 	JAPAN	 	10	 	07/03/2003	 	2003/18161	 	03/10/2003	 	4714950	 	Next formality 03-OCT-0

A-1

   EXHIBIT B  

 FORM OF ASSIGNMENT AGREEMENT  

        This Assignment Agreement (this "Assignment") is entered into and effective as of this            day
of                        , 2004, and is by and among CIBA
Vision AG ("CIBA AG"), CIBA Vision Corporation ("CIBA Corp.") and Refocus Ocular, Inc. ("Refocus") (collectively, CIBA AG and CIBA Corp. are hereinafter referred to as "CIBA," and CIBA and
Refocus are collectively hereinafter referred to as the "Parties"). Reference is hereby made to that certain License Transfer and Transition Services Agreement, dated as of January 30, 2004,
among Refocus Group, Inc. and the Parties (the "Transfer Agreement"). Capitalized terms used but not otherwise defined herein shall have the meanings ascribed thereto in the Transfer Agreement. 

W I T N E S S E T H:  

        WHEREAS, pursuant to the Transfer Agreement, CIBA agrees to grant, transfer, convey and assign to Refocus, all of CIBA AG's, CIBA Corp.'s and their respective
affiliates' right, title and interest in and to any and all patents and marks, whether issued or pending, relating to the Products and the manufacture, marketing and sale of the Products; 

        WHEREAS,
CIBA or its affiliates are the owners of all right, title and interest in and to certain inventions, and improvements, modifications, alterations and additions to the Products,
aspects of which may be patentable (collectively referred to hereinafter as the "Patent Rights"). 

        WHEREAS,
CIBA or its affiliates have adopted, used and are using, and are the owners of all right, title and interest in and to the trademarks and the trademark registrations issued in
the United States of America (collectively the "U.S. Marks") as shown on Exhibit A attached hereto and incorporated herein; and 

        WHEREAS,
CIBA or its affiliates have adopted, used and are using, and are the owners of all right, title and interest in and to the trademarks and the trademark registrations in
countries foreign to the
United States of America (the "Foreign Marks") as shown on Exhibit A attached hereto and incorporated herein; and 

        WHEREAS,
CIBA or its affiliates have also identified, designed and applied for federal registration of certain proposed trademarks before the United States Patent and Trademark Office
under section 1(b) of the Trademark Act (15 U.S.C. 1051(b), as amended), asserting in each such trademark application a bona fide intention to use such proposed trademark in commerce in manners
common to the industry (collectively, the "CIBA Intent-to-Use Applications"), as shown on Exhibit A attached hereto and incorporated herein; and 

        WHEREAS,
Refocus is desirous of acquiring all of CIBA's and its affiliates' right, title and interest in and to the Patent Rights, the U.S. Marks and the Foreign Marks (collectively
referred to herein as the "Marks"), as well as any right, title or interest CIBA or its affiliates may acquire in any such proposed trademark or federal registration granted from any of the CIBA
Intent-to-Use Applications. 

        NOW,
THEREFORE, for good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged and confessed, the Parties hereto agree as follows: 

	1.
	CIBA
and its affiliates hereby grant, transfer, convey and assign to Refocus, and Refocus does hereby accept, all of CIBA's and its affiliates' right, title and interest in, to and
under the Patent Rights, including, without limitation, rights to any and all existing causes of action relating to the Patent Rights, and to past damages associated therewith. CIBA and its affiliates
represent and warrant that they do not own or control any domestic or foreign Letters Patent or any application for any such Letters Patent related to the Products, including any continuation,
division, renewal, 

B-1

 

substitution
or reissue thereon, nor has CIBA or its affiliates otherwise pursued Letters Patent related to the Products. 

	2.
	CIBA
and its affiliates hereby grant, transfer, convey and assign to Refocus, and Refocus does hereby accept, all of CIBA's and its affiliates' right, title and interest, including,
but not limited to, rights to existing causes of action and the right to past damages associated therewith, in and to the Marks together with the goodwill of the business symbolized by the same.

	3.
	CIBA
and its affiliates hereby grant, transfer, convey and assign to Refocus, and Refocus does hereby accept, all of CIBA's and its affiliates' right, title and interest, including but
not limited to, right to existing causes of action and the right to past damages associated therewith, in and to the CIBA Intent-to-Use Applications, as part of the entire
business or portion thereof to which the related marks pertain together with the goodwill of the business symbolized by the same.

	4.
	Upon
the acceptance by the United States Patent and Trademark Office of (i) an "Amendment to Allege Use" under 37 C.F.R. "2.76 or (ii) a "Statement of Use" under 37
C.F.R. " 2.88, in any of the CIBA Intent-to-Use Applications, CIBA or its affiliates will automatically assign to Refocus, and Refocus will automatically accept, without any
further action by either of the Parties, all right, title and interest, including, but not limited to, rights to existing causes of action and the right to past damages associated therewith, in and to
the trademark, defined by such CIBA Intent-to-Use Applications, together with the goodwill of the business symbolized by the same, and any federal registration ultimately
granted by the United States Patent and Trademark Office on such CIBA intent-to-use application, if any.

	5.
	CIBA
and its affiliates covenant that Refocus will, upon its request, be provided promptly with all pertinent facts and documents relating to any of the Patent Rights, the Marks and
the CIBA Intent-to-Use Applications, as may be known and accessible to CIBA or its affiliates and will testify as to the same in any interference, litigation or other
controversy related thereto and will promptly execute and deliver to Refocus or its legal representative any and all papers, instruments or affidavits required to apply for, obtain, maintain and
enforce any of the Patent Rights or the Marks and the CIBA Intent-to-Use Applications that may be necessary or desirable to carry out the purposes hereof.

	6.
	The
Parties agree that this Assignment will inure to the benefit of, and be binding upon, their respective subsidiaries and affiliates, together with their respective successors and
assigns.

	7.
	The
Parties agree that this Assignment will be governed by and enforced under the laws of the State of Texas. The prevailing party in any such dispute will be entitled to recover, in
addition to any other relief granted, reasonable attorney fees and expenses related to such dispute.

	8.
	The
Parties agree that all notices under this Assignment will be made in writing and will be deemed given when: (1) hand delivered to; or (2) received in the United
States mail, registered with proper postage prepaid and properly addressed, return receipt requested, by a particular party. 

B-2

 

        NOW
THEREFORE, the Parties hereto have their duly authorized agents execute this Assignment on their behalf. 

	CIBA VISION AG	 	CIBA VISION CORPORATION
	

By:	
 	

 	
 	

By:	
 	

 
	 	 	
	 	 	 	

	Name:	 	 	 	Name:	 	 
	 	 	
	 	 	 	

	Title:	 	 	 	Title:	 	 
	 	 	
	 	 	 	

	Date:	 	 	 	Date:	 	 
	 	 	
	 	 	 	

	
REFOCUS OCULAR, INC.	
 	

 	
 	

 
	

By:	
 	

 	
 	

 	
 	

 
	 	 	
	 	 	 	 
	Name:	 	 	 	 	 	 
	 	 	
	 	 	 	 
	Title:	 	 	 	 	 	 
	 	 	
	 	 	 	 
	Date:	 	 	 	 	 	 
	 	 	
	 	 	 	 

B-3

 
EXHIBIT A

TO

ASSIGNMENT AGREEMENT  

	BU
 
	 	trademark
	 	country
	 	class(es)
	 	fil.date
	 	fil.nr.
	 	reg.date
	 	reg.nr.
	 	status

	CIBA VISION SURGICAL	 	PRESVIEW	 	AUSTRALIA	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	BENELUX	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	BRAZIL	 	10	 	24/01/2003	 	825201462	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	CANADA	 	 	 	21/01/2003	 	1165423	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	CTM	 	10	 	20/01/2003	 	30156'9	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	ESTONIA	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	FRANCE	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	INTERNATIONAL	 	10	 	21/01/2003	 	796676	 	21/01/2003	 	796676	 	Next formality 21-JAN-08
	CIBA VISION SURGICAL	 	PRESVIEW	 	JAPAN	 	10	 	21/01/2003	 	796676	 	21/01/2003	 	796676	 	Next formality 21-JAN-06
	CIBA VISION SURGICAL	 	PRESVIEW	 	LATVIA	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	LITHUANIA	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	MEXICO	 	10	 	21/01/2003	 	584510	 	27/02/2003	 	781331	 	Next formality 27-FEB-06
	CIBA VISION SURGICAL	 	PRESVIEW	 	NEW ZEALAND	 	10	 	22/01/2003	 	672216	 	24/07/2003	 	672216	 	Next formality 22-JAN-10
	CIBA VISION SURGICAL	 	PRESVIEW	 	NORWAY	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	RUSSIAN FED.	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	SINGAPORE	 	10	 	21/01/2003	 	796676	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	SOUTH AFRICA	 	10	 	20/01/2003	 	2003/859	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	SOUTH KOREA	 	10	 	20/01/2003	 	2003/2603	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	SWITZERLAND	 	10	 	14/01/2003	 	180/2003	 	21/01/2003	 	506619	 	Next formality 21-JAN-08
	CIBA VISION SURGICAL	 	PRESVIEW	 	THAILAND	 	10	 	24/01/2003	 	509339	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW	 	U.S.A.	 	10	 	21/01/2003	 	78/205322	 	 	 	 	 	Registration in progress
	CIBA VISION SURGICAL	 	PRESVIEW (KATAKANA)	 	JAPAN	 	10	 	07/03/2003	 	2003/18161	 	03/10/2003	 	4714950	 	Next formality 03-OCT-0

B-4

   EXHIBIT C  

 SERVICES TO BE PERFORMED BY CIBA  

I.     Product Inventory Tasks  

	1.
	Provide
an updated inventory status of blades and implants.

	2.
	Check
label inventory at Atrion for sufficiency and content.

	3.
	Facilitate
completion, through packaging and sterilization, of all existing blade and implant inventory for final inventory storage at Atrion.

	4.
	Facilitate
completion of implant inspection and cleaning at Cidra and QA release, ship to Atrion for packaging.

	5.
	Re-label
finished implant kits remaining at Licensee, CIBA and their respective affiliates left over from sterilization validation.

	6.
	Complete
cutting and folding of package inserts for Atrion inventory build.

	7.
	Develop,
subject to Licensor review and approval, strategy for expired blade and implant inventory.

	8.
	Facilitate
logistics for furtherance of aging study at Atrion to extend expiration dating, provided that Licensor shall be responsible for any additional package stability testing that
may be required.

	9.
	Label
all W&H and D&K equipment with clinical labeling and deliver to Licensor's designated carrier for shipment. 

II.    CE Mark Tasks  

	1.
	Continue
reasonable best efforts to finalize and issue on a timely basis appropriate CE Mark certification on the implant and blade, subject to satisfaction of reasonable technical
matters by Refocus.

	2.
	Obtain
final papers from W&H testing of complete Drive Control Unit, facilitate QA release.

	3.
	Obtain
CE Mark certifications and equipment dossier from W&H and D&K.

	4.
	Facilitate
completion of documents needed for Licensee's, CIBA's or their affiliate's CE Mark for the implants and the blade.

	5.
	Facilitate
vigilance reporting as specified in the technical agreement to be executed by the parties in accordance with Section E.13 of the License Transfer and Transition
Services Agreement, by and between Licensor, Refocus, Licensee and CIBA.

	6.
	Provide
a complete copy of Licensee's, CIBA's or their respective affiliates' CE Mark dossier regarding the implant. 

III.  Other  

	1.
	Provide
copies of German Ethics Committee approvals, if any.

	2.
	Provide
copies of European Union protocol for clinical studies, if any. 

C-1

   EXHIBIT D  

 LETTER TO OTHER PARTIES  

Dear                        :

        This
letter advises that CIBA Vision has reached agreement with Refocus Group, Inc. (formerly known as Presby Corp) for Refocus Group to reacquire the rights to the PresVIEW
products related to the surgical treatment of presbyopia, glaucoma and ocular hypertension worldwide, effective January 30, 2004. 

        Under
our original License Agreement with Refocus Group, which became effective in March 2002, CIBA Vision obtained certain exclusive rights to Refocus Group's patents and
PresVIEW products. In connection with our recent mutual agreement, we have assigned and returned all licensed rights in the original Agreement back to Refocus. 

        As
a result, you should be advised that CIBA Vision will no longer be licensed to use or commercialize any Refocus products, patents or trademarks including, and without imitation, the
PresVIEW Scleral Implants, the PresVIEW Incision System and all other components related to the PresVIEW Scleral Spacing Procedure (SSP). These rights are now the exclusive rights of Refocus Group. We
will, however, assist Refocus on certain contracted services during 2004 to help ensure a smooth transition of key activities. 

        This
decision was reached as part of the outcome of our decision in August 2003 to explore strategic alternatives regarding our surgical business, including its potential sale. We
have enjoyed our association with Refocus and wish them much success in the future. 

        To
the extent that we have a confidentiality agreement, intellectual property rights agreement or other similar understanding with you directed toward the Refocus products, please
consider this letter as
notice of our assignment of those rights to Refocus. In addition and where contracted or applicable, you are hereby released to transfer the maintenance of confidentiality owed us to Refocus. 

        We
value our relationship with you and expect that it will be unaffected by this mutual decision with Refocus. We look forward to continuing to work with you regarding other CIBA
products. 

	 	 	Sincerely,
	

 	
 	

	cc:
	Refocus
Ocular, Inc. 

D-1

   EXHIBIT E  

 OTHER PARTIES  

Intentionally
Omitted. 

E-1

QuickLinks

Exhibit 10.24

LICENSE TRANSFER AND TRANSITION SERVICES AGREEMENTQuickLinks
 -- Click here to rapidly navigate through this document

 
 

Exhibit 4.4    
    

 
 

EARTHLINK, INC.
  
    STOCK INCENTIVE PLAN
  
    (as amended effective October 23, 2003)    
    

  

 
 

TABLE OF CONTENTS    
    

	 
	 
	 	Page

	ARTICLE I    DEFINITIONS	 	1
	 	1.01.	Acceleration Date	 	1
	 	1.02.	Administrator	 	1
	 	1.03.	Agreement	 	1
	 	1.04.	Award	 	1
	 	1.05.	Board	 	1
	 	1.06.	Cause	 	1
	 	1.07.	Change in Control	 	1
	 	1.08.	Code	 	2
	 	1.09.	Committee	 	2
	 	1.10.	Common Stock	 	2
	 	1.11.	Company	 	2
	 	1.12.	Control Change Date	 	2
	 	1.13.	Corresponding SAR	 	2
	 	1.14.	Deferred Compensation Program	 	2
	 	1.15.	Deferred Stock Benefit	 	2
	 	1.16.	Employee	 	2
	 	1.17.	Exchange Act	 	2
	 	1.18.	Fair Market Value	 	2
	 	1.19.	Incentive Stock Option	 	2
	 	1.20.	Initial Value	 	3
	 	1.21.	Insider	 	3
	 	1.22.	Named Executive Officer	 	3
	 	1.23.	Nonqualified Stock Option	 	3
	 	1.24.	Option	 	3
	 	1.25.	Participant	 	3
	 	1.26.	Performance Award	 	3
	 	1.27.	Permitted Transferee	 	3
	 	1.28.	Person	 	3
	 	1.29.	Plan	 	3
	 	1.30.	Restricted Stock	 	3
	 	1.31.	Restricted Stock Unit	 	3
	 	1.32.	SAR	 	4
	 	1.33.	Subsidiary	 	4
	 	1.34.	Ten Percent Shareholder	 	4
	 	1.35.	Vested	 	4
	 	1.36.	Voting Stock	 	4
	

ARTICLE II    PURPOSES	
 	

4
	

ARTICLE III    ADMINISTRATION	
 	

4
	

ARTICLE IV    ELIGIBILITY	
 	

5
	

ARTICLE V    STOCK SUBJECT TO PLAN	
 	

6
	 	5.01.	Shares Issued.	 	6
	 	5.02.	Aggregate Limits.	 	6
	 	5.03.	Individual Limits.	 	6
	 	5.04.	Deferred Shares.	 	6
	 	5.05.	Reallocation of Shares.	 	6

i

 

	

ARTICLE VI    TERMS AND CONDITIONS OF ALL OPTIONS	
 	

7
	 	6.01.	Grants.	 	7
	 	6.02.	Option Price.	 	7
	 	6.03.	Maximum Option Period.	 	7
	 	6.04.	Nontransferability.	 	7
	 	6.05.	Change in Control.	 	7
	 	6.06.	Exercise.	 	8
	 	6.07.	Payment.	 	8
	 	6.08.	Shareholder Rights.	 	8
	 	6.09.	Reload Option.	 	8
	

ARTICLE VII    ADDITIONAL TERMS AND CONDITIONS OF INCENTIVE STOCK OPTIONS	
 	

9
	 	7.01.	Employee Status.	 	9
	 	7.02.	Exercise Price.	 	9
	 	7.03.	Aggregate Exercise Limits.	 	9
	 	7.04.	Restrictions on Ten-Percent Shareholders.	 	9
	 	7.05.	Validity of Options.	 	9
	 	7.06.	Notification Upon Sale.	 	9
	 	7.07.	No Liability of Company.	 	9
	

ARTICLE VIII    TERMS AND CONDITIONS OF RESTRICTED STOCK	
 	

9
	 	8.01.	Grants.	 	9
	 	8.02.	Payment.	 	10
	 	8.03.	Maximum Vesting Period.	 	10
	 	8.04.	Nontransferability.	 	10
	 	8.05.	Change in Control.	 	10
	 	8.06.	Vesting.	 	11
	 	8.07.	Shareholder Rights.	 	11
	

ARTICLE IX    TERMS AND CONDITIONS OF RESTRICTED STOCK UNITS	
 	

11
	 	9.01.	Grants.	 	11
	 	9.02.	Maximum Payment Period.	 	11
	 	9.03.	Nontransferability.	 	11
	 	9.04.	Change in Control.	 	12
	 	9.05.	Right to Receive Payment.	 	12
	 	9.06.	Form of Payment.	 	12
	 	9.07.	Shareholder Rights.	 	12
	

ARTICLE X    TERMS AND CONDITIONS OF SARS	
 	

13
	 	10.01.	Grants.	 	13
	 	10.02.	Maximum SAR Period.	 	13
	 	10.03.	Nontransferability.	 	13
	 	10.04.	Change in Control.	 	13
	 	10.05.	Exercise.	 	14
	 	10.06.	Special Rules for Corresponding SARs.	 	14
	 	10.07.	Payment Upon Exercise of SAR.	 	14
	 	10.08.	Shareholder Rights.	 	14
	

ARTICLE XI    TERMS AND CONDITIONS OF PERFORMANCE AWARDS	
 	

15
	 	11.01.	Grants.	 	15
	 	11.02.	Maximum Performance Award Period.	 	15

ii

 

	 	11.03.	Nontransferability.	 	15
	 	11.04.	Change in Control.	 	16
	 	11.05.	Payment of Performance Award.	 	16
	 	11.06.	Shareholder Rights.	 	16
	

ARTICLE XII    ADDITIONAL TERMS AND CONDITIONS APPLICABLE TO ALL AWARDS	
 	

16
	 	12.01.	Interruption of Employee or Independent Contractor Status.	 	16
	 	12.02.	Performance Objectives.	 	16
	 	12.03.	Other Conditions.	 	17
	 	12.04.	Forfeiture Provisions.	 	17
	

ARTICLE XIII    DEFERRED BENEFITS	
 	

17
	

ARTICLE XIV    LIMITATION ON BENEFITS	
 	

17
	

ARTICLE XV    ADJUSTMENT UPON CHANGE IN COMMON STOCK	
 	

18
	

ARTICLE XVI    COMPLIANCE WITH LAW AND APPROVAL OF REGULATORY BODIES	
 	

19
	 	16.01.	Compliance.	 	19
	 	16.02.	Postponement of Exercise or Payment.	 	19
	 	16.03.	Forfeiture of Payment.	 	19
	

ARTICLE XVII    GENERAL PROVISIONS	
 	

20
	 	17.01.	Effect on Employment and Service.	 	20
	 	17.02.	Unfunded Plan.	 	20
	 	17.03.	Tax Withholding and Reporting.	 	20
	 	17.04.	Reservation of Shares.	 	20
	 	17.05.	Governing Law.	 	20
	 	17.06.	Other Actions.	 	20
	

ARTICLE XVIII    AMENDMENT	
 	

21
	

ARTICLE XIX    DURATION OF PLAN	
 	

21
	

ARTICLE XX    EFFECTIVE DATE OF PLAN	
 	

21
	

ARTICLE XXI    CLAIMS PROCEDURES	
 	

21
	

ARTICLE XXII    RULES OF CONSTRUCTION	
 	

22

iii

 
 

EARTHLINK, INC.
  STOCK INCENTIVE PLAN
  (as amended effective October 23, 2003)    
    

 
  ARTICLE I
  DEFINITIONS    
    

        1.01.     Acceleration Date means the earlier of (i) the date that the Board approves a transaction or
series of transactions that, if consummated, would result in a Change in Control or (ii) the date that an agreement is entered into with respect to a transaction or series of transactions that,
if consummated, would result in a Change in Control. 

        1.02.     Administrator means the Committee and any delegate of the Committee that is appointed in accordance with
Article III. 

        1.03.     Agreement means a written agreement (including any amendment or supplement thereto) between the Company
and a Participant specifying the terms and conditions of an Award granted to the Participant under the Plan. 

        1.04.     Award means an Option, Performance Award, Restricted Stock, Restricted Stock Unit or SAR awarded under
the Plan. 

        1.05.     Board means the Board of Directors of the Company. 

        1.06.     Cause has the same definition as under any employment or service agreement between the Company or any
Subsidiary and the Participant or, if no such employment or service agreement exists or if such employment or service agreement does not contain any such definition, Cause means (i) the
Participant's willful and repeated failure to comply with the lawful directives of the Board, the Board of Directors of any Subsidiary or any supervisory personnel of the Participant; (ii) any
criminal act or act of dishonesty or willful misconduct by the Participant that has a material adverse effect on the property, operations, business or reputation of the Company or any Subsidiary;
(iii) the material breach by the Participant of the terms of any confidentiality or noncompetition agreement that the Participant has with the Company or any Subsidiary or (iv) acts by
the Participant of willful malfeasance or gross negligence in a matter of material importance to the Company or any Subsidiary. For purposes of the Plan, in no event shall any termination of
employment be deemed for Cause unless the Company's Chief Executive Officer concludes that the situation warrants a determination that the Participant's employment terminated for Cause; in the case of
the Chief Executive Officer, any determination that the Chief Executive Officer's employment terminated for Cause shall be made by the Board acting without the Chief Executive Officer. 

        1.07.     Change in Control means the occurrence of any of the following: (i)(a) the Company consolidates with, or
merges with or into, another Person, (b) there is a merger, reorganization, consolidation, share exchange or other transaction involving the Voting Stock of the Company, (c) the Company
sells, assigns, conveys, transfers, leases or otherwise disposes of all or substantially all of the assets of the Company to any Person, (d) any Person consolidates with, or merges with or
into, the Company, or (e) any similar event, where with respect to each of the events described in (a) through (e) the outstanding Voting Stock of the Company is converted into or
exchanged for cash, securities or other property, except that none of the foregoing events will constitute a Change in Control where the outstanding Voting Stock of the Company is converted into or
exchanged for Voting Stock of the surviving or transferee Person and the beneficial owners of the Voting Stock of the Company immediately before such event own, directly or indirectly, Voting Stock
representing not less than 60 percent of the voting power of the Voting Stock of the surviving or transferee Person immediately after such event, or (ii) any transaction that results in
any person, other than a trustee or other fiduciary holding securities under an employee benefit plan of the Company, beneficially owning Voting Stock of the Company representing, directly or
indirectly, 40 percent or more of the voting power of the Voting Stock of the Company, or (iii) the approval by the holders of Voting Stock of the Company of any plan or proposal for
liquidation or dissolution of the Company or (iv) the consummation of any 

 

other
transaction that a majority of the Board, in its sole and absolute discretion, determines constitutes a Change in Control for purposes of this Plan. 

        1.08.     Code means the Internal Revenue Code of 1986, as amended. 

        1.09.     Committee means the Compensation Committee of the Board, if the Board appoints one, or the Board itself
if no Compensation Committee is appointed. If such Compensation Committee is appointed, if and to the extent deemed necessary by the Board, such Compensation Committee shall consist of two or more
non-employee outside directors, all of whom are "non-employee directors" within the meaning of Rule 16b-3 under the Exchange Act and "outside directors"
within the meaning of Code Section 162(m). 

        1.10.     Common Stock means the voting common stock, $.01 par value per share, of the Company. 

        1.11.     Company means EarthLink, Inc. 

        1.12.     Control Change Date means the date on which a Change in Control occurs. If a Change in Control occurs on
account of a series of transactions, the "Control Change Date" is the date of the last of such transactions. 

        1.13.     Corresponding SAR means a SAR that is granted in relation to a particular Option and that can be
exercised only upon the surrender to the Company, unexercised, of that portion of the Option to which the Corresponding SAR relates. 

        1.14.     Deferred Compensation Program means any plan or program that the Company may establish that is intended
to constitute a deferred compensation plan for a select group of management and highly compensated employees of the Company and its Subsidiaries, pursuant to which eligible individuals may elect to
defer the receipt of specified benefits or to which specified benefits otherwise deferred will be credited (whether or not such benefits are deferred in connection with Awards granted under this
Plan). 

        1.15.     Deferred Stock Benefit means the specified benefit that the eligible individual elected to defer under
the Deferred Compensation Program or that otherwise was deferred and credited under the Deferred Compensation Program that must be distributed or paid, if at all, in shares of Common Stock. A Deferred
Stock Benefit will be paid pursuant to the terms of the Deferred Compensation Program and at such time or times as are set forth therein (which may be more than 10 years from the date of grant
of the Award in connection with which the receipt of Common Stock or cash or other consideration was deferred). 

        1.16.     Employee means any person whom the Company or any Subsidiary employs under the rules of Code
Section 3401(c) and the regulations thereunder. 

        1.17.     Exchange Act means the Securities Exchange Act of 1934, as amended. 

        1.18.     Fair Market Value of a share of Common Stock means, on any given date, the fair market value of a share
of Common Stock as the Administrator in its discretion shall determine; provided, however, that the Administrator shall determine Fair Market Value without regard to any restriction other than a
restriction which, by its terms, will never lapse and, if the shares of Common Stock are traded on any stock exchange, the Fair Market Value of a share of Common Stock shall be the closing price of a
share of Common Stock as reported on such stock exchange on such date, or if the shares of Common Stock are not traded on such stock exchange on such date, then on the next preceding day that the
shares of Common Stock were traded on such stock exchange, all as reported by such source as the Administrator shall select. The Fair Market Value that the Administrator determines shall be final,
binding and conclusive on the Company, any Subsidiary and each Participant. 

        1.19.     Incentive Stock Option means an Option that is subject to Code Section 422. 

2

 

        1.20.     Initial Value means, with respect to a SAR that is not a Corresponding SAR, the Fair Market Value of a
share of Common Stock on the date of grant of the SAR and, with respect to a SAR that is a Corresponding SAR, the Option price of the related Option. 

        1.21.     Insider means an individual who is an officer, director or ten percent (10%) beneficial owner of any
class of the Company's equity securities that are registered pursuant to Section 12 of the Exchange Act, as more fully described under Section 16 of the Exchange Act. 

        1.22.     Named Executive Officer means a Participant who as of the last day of a taxable year, is the chief
executive officer of the Company (or is acting in such capacity) or one of the four highest compensated officers of the Company (other than the chief executive officer) or is otherwise one of the
group of "covered employees", as defined in the Treasury Regulations promulgated under Code Section 162(m). 

        1.23.     Nonqualified Stock Option means an Option that is not subject to Code Section 422. 

        1.24.     Option means a stock option that entitles the holder to purchase from the Company a stated number of
shares of Common Stock at the price set forth in the Agreement that specifies the terms and conditions of the Option. 

        1.25.     Participant means an Employee, contractor, agent or other service provider of the Company or any
Subsidiary, including a member of the Board, who satisfies the requirements of Article IV and whom the Administrator selects to receive an Award. 

        1.26.     Performance Award means an Award that entitles the Participant to receive a specified value in cash or
Common Stock of the Company upon the attainment of the performance objectives set forth in the Agreement that specifies the terms and conditions of the Performance Award. 

        1.27.     Permitted Transferee means with respect to a Participant (i) any child, stepchild, grandchild,
parent, stepparent, grandparent, spouse, former spouse, sibling, niece, nephew, mother-in-law, father-in-law, son-in-law,
daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships; (ii) a trust in which any of the
individuals listed in (i) above own one hundred percent (100%) of the beneficial interests; or (iii) any other entity in which the Participant or any of the individuals listed in
(i) above own one hundred percent (100%) of the ownership interests. 

        1.28.     Person means any individual, corporation, partnership, limited liability company, joint venture,
incorporated or unincorporated association, joint-stock company, trust, unincorporated organization or government or other agency or political subdivision thereof or any other entity of any kind. 

        1.29.     Plan means this EarthLink, Inc. Stock Incentive Plan (as amended effective October 23,
2003), in its current form and as hereafter amended. 

        1.30.     Restricted Stock means Common Stock granted or sold to a Participant under the Plan that is subject to
the restrictions, if any, set forth in the Plan and in the Agreement that specifies the terms and conditions of the Restricted Stock. Shares of Common Stock shall cease to be Restricted Stock when, in
accordance with the terms and conditions of the Plan and the applicable Agreement, they become Vested. 

        1.31.     Restricted Stock Unit means an Award, stated with respect to a specified number of shares of Common
Stock, that entitles the Participant to receive one share of Common Stock with respect to each Restricted Stock Unit that becomes payable under the terms and conditions of the Plan and the applicable
Agreement. If the applicable Agreement so provides, if the Company pays any cash dividends on Common Stock, the number of Restricted Stock Units the Participant is granted shall be increased by the
number of Restricted Stock Units, rounded down to the nearest whole number, equal to (a) the product of the number of the Participant's outstanding Restricted Stock Units as of the 

3

 

record
date for such dividend multiplied by the per share amount of the dividend divided by (b) the Fair Market Value of a share of Common Stock on the payment date of such dividend. 

        1.32.     SAR means a stock appreciation right that entitles the Participant to receive, with respect to each share
of Common Stock encompassed by the exercise of the SAR, the excess of the Fair Market Value on the date of exercise of each such share over the Initial Value. References to SARs include both
Corresponding SARs and SARs that are not Corresponding SARs, unless the context requires otherwise. 

        1.33.     Subsidiary means any corporation (other than the Company) in an unbroken chain of corporations beginning
with the Company, if at the time of the granting of the Award, each of the corporations other than the last corporation in the unbroken chain owns stock possessing 50 percent or more of the
total combined voting power of all classes of stock in one of the other corporations in such chain. 

        1.34.     Ten Percent Shareholder means any individual who (considering the stock attribution rules described in
Code Section 424(d)) owns stock possessing more than 10 percent of the total combined voting power of all classes of stock of the Company, its parent within the meaning of Code
Section 424(e) or any Subsidiary. 

        1.35.     Vested means nonforfeitable and transferable within the meaning of Code Section 83. 

        1.36.     Voting Stock with respect to any specified Person means any class or classes of stock or other ownership
rights of the specified Person pursuant to which the holders thereof have the general voting power under ordinary circumstances to elect at least a majority of the board of directors, managers or
trustees of the specified Person. 

 
 

ARTICLE II
  PURPOSES    
    

        This Plan is intended to assist the Company and its Subsidiaries in recruiting and retaining individuals with ability and initiative by enabling such persons to
participate in the future success of the Company and to associate their interests with those of the Company and its shareholders. The Plan is intended to permit the grant of Options, Restricted Stock,
Restricted Stock Units, SARs and Performance Awards. The proceeds the Company receives from the sale of Common Stock pursuant to any Participant's exercise of an Option or purchase of Restricted Stock
shall be used for general corporate purposes. 

 
 

ARTICLE III
  ADMINISTRATION    
    

        The Administrator shall have the complete authority to grant Awards on such terms (not inconsistent with the provisions of this Plan), as the Administrator may
consider appropriate. Such terms may include conditions (in addition to those contained in this Plan) on the exercisability, Vesting, payment or forfeiture of any Award. The Administrator also shall
administer the Plan. The Administrator shall have the complete authority to interpret all provisions of this Plan; to prescribe the form of Agreements; to accelerate the exercisability, Vesting or
payment of an Award as a result of a Change in Control or otherwise; to adopt, amend and rescind rules and regulations pertaining to the administration of the Plan; and to make all other
determinations necessary or advisable for the administration of the Plan. Notwithstanding the foregoing, however, to the extent the Administrator is exercising its discretion regarding the grant of an
Award, the Administrator shall act without the individual to whom the Award relates. The express grant in the Plan of any specific power to the Administrator shall not be construed as limiting any
power or authority of the Administrator. Any decision or action of the Administrator in connection with the administration of this Plan shall be final, 

4

 

conclusive
and binding on all persons. Neither the Administrator nor any member of the Committee shall be liable for any act done or not done in good faith with respect to this Plan, any Agreement or
any Award. 

        The
Administrator may act only by decision of a majority of its members, except that the Administrator, in its discretion, may delegate to another Committee of the Board all or part of
the Administrator's authority and duty with respect to grants of Awards, and provided that applicable law so permits, may delegate to one or more officers of the Company all or part of the
Administrator's authority and duties with respect to grants of Awards to Participants who are not Insiders or Named Executive Officers. The Administrator may amend or revoke the terms of such
delegation at any time but such action shall not invalidate any prior actions of the Administrator's delegate or delegates that were consistent with the terms of the Plan. 

        If
and to the extent deemed necessary by the Board (i) all Awards to an Insider shall be approved by the Board or by a Committee comprised of two or more non-employee
directors within the meaning of Rule 16b-3 of the Exchange Act, unless such Awards will be held by the Participant at least six months after the date they are granted to such
Participant and (ii) all Awards to a Named Executive Officer shall be approved by a Committee comprised solely of two or more outside directors within the meaning of Code Section 162(m). 

        The
Company shall bear all expenses of administering this Plan. The Company shall indemnify and hold harmless each person who is or shall have been a member of any Board or Committee
acting as the Administrator, or any delegate of such, against and from any cost, liability, loss or expense that may be imposed upon or reasonably incurred by such person in connection with or
resulting from any action, claim, suit, or proceeding to which such person may be a party or in which such person may be involved by reason of any action taken or not taken under the Plan and against
and from any and all amounts paid by such person in settlement thereof, with the Company's approval, or paid by such person in satisfaction of any judgment in any such action, suit, or proceeding
against such person, provided he or she shall give the Company an opportunity, at its own expense, to handle and defend the same before he or she undertakes to handle and defend it on his or her own
behalf. Notwithstanding the foregoing, the Company shall not indemnify and hold harmless any such person if (i) applicable law prohibits such indemnification or (ii) such person did not
act in good faith and in a manner that such person believed to be consistent with the Plan and such person's conduct constituted gross negligence or willful misconduct. The foregoing right of
indemnification shall not be exclusive of any other rights of indemnification to which such persons may be entitled under the Company's Certificate of Incorporation or Bylaws, as a matter of law or
otherwise, or under any other power that the Company may have to indemnify such person or hold him or her harmless. The provisions of the foregoing indemnity shall survive indefinitely the term of
this Plan. 

 
 

ARTICLE IV
  ELIGIBILITY    
    

        Any Employee, contractor, consultant, agent or other service provider of the Company or any Subsidiary (including a corporation that becomes a Subsidiary after
the adoption of this Plan) is eligible to receive an Award if the Administrator, in its sole discretion, determines that such person has contributed significantly or can be expected to contribute
significantly to the profits or growth of the Company or any Subsidiary. Members of the Board or the Board of Directors of any Subsidiary also may receive Awards. 

5

 

 
 

ARTICLE V
  STOCK SUBJECT TO PLAN    
    

        5.01.     Shares Issued.    On the exercise of an Option or a SAR, the grant of Restricted Stock, the
payment of a Restricted Stock Unit, or the payment of a Performance Award payable in Common Stock, the Company may deliver to the Participant (or the Participant's broker if the Participant so
directs) shares of Common Stock from its authorized but unissued shares of Common Stock or from reacquired shares of Common Stock. On the distribution or payment of Deferred Stock Benefits, the
Company may issue shares of Common Stock from its authorized but unissued shares of Common Stock or from reacquired shares of Common Stock. 

        5.02.     Aggregate Limits.    The maximum number of shares of Common Stock that may be issued under this
Plan and to which Awards may relate or which may be distributed or paid in settlement of Deferred Stock Benefits shall be 20,000,000 shares of Common Stock. Up to 1,000,000 of such shares of Common
Stock may be issued pursuant to grants of Restricted Stock and Restricted Stock Units, the exercise of SARs or the payment of Performance Awards or in settlement of Deferred Stock Benefits that
represent deferred shares of Common Stock in connection with such Awards or any other Deferred Stock Benefits to be distributed or paid under the Deferred Compensation Program (other than with respect
to Options). Up to the full 20,000,000 of such shares of Common Stock may be issued pursuant to the exercise of Options or in settlement of the Deferred Stock Benefits that represent deferred shares
of Common Stock previously subject to Options. The maximum number of shares in each instance shall be subject to adjustment as provided in Article XIV. 

        5.03.     Individual Limits.    Subject to the other limitations set forth in this Plan, no individual
may, in any calendar year, be granted aggregate Awards covering more than 1,000,000 shares of Common Stock. Performance Awards granted in any one calendar year may not provide for payments in excess
of $1,000,000. If an Award that a Participant holds is canceled and a replacement Award is issued, the canceled Award shall continue to be counted against the maximum number of shares of Common Stock
for which similar Awards may be granted to the Participant in any calendar year and any replacement Awards granted to such Participant in replacement of the canceled Awards also shall count against
such maximum limit. The maximum number of shares that may be granted in any calendar year to any individual shall be subject to adjustment as provided in Article XIV. 

        5.04.     Deferred Shares.    Shares of Common Stock issued or distributed in settlement of Deferred
Stock Benefits, shares of Common Stock subject to Awards with respect to which there is a Deferred Stock Benefit and any other Deferred Stock Benefits to be paid or distributed under the Deferred
Compensation Program shall be counted against the maximum number of shares of Common Stock that may be issued under this Plan or to which various Awards may relate unless and until such shares of
Common Stock shall not be issued because of the surrender, lapse, expiration, forfeiture or termination of any rights in such shares of Common Stock or the Deferred Stock Benefits; provided, however,
that shares of Common Stock shall be counted toward the foregoing limits only once (so that in the case of shares of Common Stock subject to Awards that are cancelled in connection with Deferred Stock
Benefits, such Shares of Common Stock shall only be counted once). If a Deferred Stock Benefit is forfeited, in whole or in part, the number of shares of Common Stock allocated to such Deferred Stock
Benefit or portion thereof may be reallocated to other Awards to be granted under the Plan or to settlement of any other Deferred Stock Benefits. However, shares of Common Stock issued in settlement
of or representing Deferred Stock Benefits that constitute earnings on deferred shares of Common Stock shall be counted separately towards the foregoing limits. 

        5.05.     Reallocation of Shares.    If an Option or SAR is terminated, in whole or in part, for any
reason other than its exercise (including an exercise that results in a Deferred Stock Benefit) or payment, or if any Restricted Stock is canceled, expires or terminates without the Restricted Stock
becoming Vested, or if any Performance Award or Restricted Stock Unit is terminated without payment 

6

 

of
shares of Common Stock, the number of shares of Common Stock allocated to such Award or the terminated portion thereof may be reallocated to other Awards to be granted under this Plan, subject to
the aggregate limits described above. 

 
 

ARTICLE VI
  TERMS AND CONDITIONS OF ALL OPTIONS    
    

        6.01.     Grants.    In accordance with the provisions of Article IV, the Administrator will
designate each individual to whom an Option is to be granted and will specify the number of shares of Common Stock covered by such grant and whether the Option is an Incentive Stock Option or a
Nonqualified Stock Option. Incentive Stock Options also must comply with the provisions of Article VII. An Option may be granted with or without a Corresponding SAR. The date an Option is
granted shall be the date on which the Administrator has approved the terms and conditions of the Option. Each Option granted under the Plan shall be evidenced by an Agreement in such form and
containing such terms, conditions and restrictions (not inconsistent with this Plan) as the Administrator in its sole discretion determines. 

        6.02.     Option Price.    The Administrator on the date of grant shall determine the price per share for
Common Stock payable upon the exercise of an Option except that the price per share for Common Stock shall not be less than the Fair Market Value of a share of Common Stock on the date of grant of the
Option. 

        6.03.     Maximum Option Period.    The Administrator on the date of grant shall determine the maximum
period in which an Option may be exercised, except that no Option shall be exercisable after the expiration of 10 years from the date such Option is granted. The terms of any Option may provide
that it is exercisable for a period less than such maximum period. 

        6.04.     Nontransferability.

        (a)   Except
as set forth in Section 6.04(b) below, each Option granted under this Plan shall be nontransferable except by will or by the laws of descent and
distribution. In the event of any such transfer of an Option, the Option must be transferred in its entirety to the same person or persons or entity or entities. Except as set forth in
Section 6.04(b) below, during the lifetime of the Participant to whom the Option is granted, only the Participant may exercise the Option. No right or interest of a Participant in any Option
shall be liable for, or subject to, any lien, obligation or liability of such Participant. 

        (b)   Notwithstanding
Section 6.04(a) above, if the applicable Agreement so provides, an Option that is not an Incentive Stock Option may be transferred by the
Participant to a Permitted Transferee. Any such transfer will be permitted only if (i) the Participant does not receive any consideration for the transfer and (ii) the Administrator
expressly approves the transfer. The Permitted Transferee shall be bound by the same terms and conditions that governed the Option during the period the Participant held it; provided, however, that
such Permitted Transferee may not transfer such Option except by will or the laws of descent and distribution. Any such transfer shall be evidenced by an appropriate written document executed by the
Participant, and a copy thereof shall be delivered to the Administrator on or prior to the effective date of the transfer. 

        6.05.     Change in Control.    Notwithstanding any provision of any Agreement, in the event of or in
anticipation of a Change in Control, the Administrator in its discretion (i) may declare that some or all outstanding Options previously granted under the Plan, whether or not then exercisable,
shall terminate as of a date on or after an Acceleration Date or before or on the Control Change Date without any payment to the holder of the Option, provided the Administrator gives prior written
notice to the Participants of such termination and gives such Participants the right to exercise their outstanding Options before such date to the extent then exercisable or (ii) may terminate
on or after an Acceleration Date or before or on the Control Change Date some or all outstanding Options 

7

 

previously
granted under the Plan, whether or not then exercisable, in consideration of payment to the holder of the Option, with respect to each share of Common Stock for which the Option is then
exercisable, of the excess, if any, of the Fair Market Value on such date of the Common Stock subject to the exercisable portion of the Option over the Option price. The payment described in
(ii) above may be made in any manner the Administrator determines, including in cash, Voting Stock or other property. The Administrator may take the actions described in (i) or
(ii) above with respect to Options that are not then exercisable whether or not the Participant will receive any payment therefor. The Administrator in its discretion may take the actions
described in (i) or (ii) above contingent on consummation of the Change in Control and with respect to some or all outstanding Options, whether or not then exercisable, or on an
Option-by-Option basis, which actions need not be uniform with respect to all outstanding Options. However, the Options shall not be terminated to the extent that written
provision is made for their continuance, assumption or substitution by a successor employer or its parent or subsidiary in connection with the Change in Control. 

        6.06.     Exercise.    The Administrator in its discretion may but need not declare that some or all
outstanding Options previously granted under the Plan shall be exercisable, in whole or in part, on the earlier of (i) immediately before the time the Administrator takes either of the actions
described in (i) or (ii) of Section 6.06 above or (ii) as of the Control Change Date; if the Administration makes such declaration, all such Options which became
exercisable shall remain exercisable thereafter in accordance with the terms of the Plan and the applicable Agreement. The Administrator may act with respect to some or all outstanding Options or on
an Option-by-Option basis, which actions need not be uniform with respect to all outstanding Options. Subject to the preceding sentences, an Option may be exercised in whole at
any time or in part from time to time and at such times and in compliance with such requirements as the Administrator shall determine and as set forth in the applicable Agreement. An Option granted
under this Plan may be exercised with respect to any number of whole shares less than the full number of shares for which the Option could be exercised. A partial exercise of an Option shall not
affect the right to exercise the Option from time to time in accordance with this Plan and the applicable Agreement with respect to the remaining shares subject to the Option. To the extent an Option
relates to a Corresponding SAR, upon exercise of or payment with respect to such Option, the Participant shall surrender to the Company, unexercised, the related portion of the Corresponding SAR. 

        6.07.     Payment.    Unless the Agreement provides otherwise, payment of the Option price shall be made
in cash or a cash equivalent acceptable to the Administrator. If the Agreement so provides, the Administrator, in its discretion and provided applicable law so permits, may allow a Participant to pay
all or part of the Option price (i) by surrendering shares of Common Stock to the Company that the Participant has held for at least six months; (ii) by a cashless exercise through a
broker; (iii) by such other medium of payment as the Administrator in its discretion shall authorize or (iv) by any combination of the aforementioned methods of payment. If Common Stock
is used to pay all or part of the Option price, the sum of the cash and cash equivalent and other payments and the Fair Market Value (determined as of the day preceding the date of exercise) of the
Common Stock surrendered must not be less than the Option price of the shares for which the Option is being exercised. 

        6.08.     Shareholder Rights.    No Participant shall have any rights as a shareholder with respect to
shares of Common Stock subject to an Option until the proper exercise of such Option, the payment of the Option price and any applicable withholding taxes, and the issuance to the Participant of the
certificates representing the shares of Common Stock for which the Option is exercised. The Company may include on any certificates representing shares of Common Stock issued pursuant to an Option
such legends referring to any representations, restrictions or any other applicable statements as the Company, in its discretion, shall deem appropriate. 

        6.09.     Reload Option.    The Administrator, in its discretion, may accompany the grant of an Option
with a reload Option, which shall represent an additional Option to acquire the same number of shares 

8

 

of
Common Stock as used by the Participant to pay for the original Option. The reload Option shall be subject to all of the same terms and conditions as the original Option except that (i) the
purchase price for the shares of Common Stock subject to the reload Option will be the same Fair Market Value of the shares of Common Stock that the Participant used to pay for the original Option and
(ii) such reload Option shall conform to all the provisions of the Plan at the time the original Option is exercised. 

 
 

ARTICLE VII
  ADDITIONAL TERMS AND CONDITIONS OF INCENTIVE STOCK OPTIONS    
    

        7.01.     Employee Status.    Notwithstanding any other provision of the Plan or any Agreement, the
Administrator may only grant an Incentive Stock Option to an Employee of the Company or any Subsidiary. 

        7.02.     Exercise Price.    Notwithstanding any other provision contained in the Plan or any Agreement,
no Employee may receive an Incentive Stock Option under the Plan, unless the Option price per share for such Incentive Stock Option is at least 100 percent of the Fair Market Value on the date
of grant of each share of Common Stock subject to such Incentive Stock Option. 

        7.03.     Aggregate Exercise Limits.    The Administrator may not grant an Incentive Stock Option or any
Corresponding SAR that relates to an Incentive Stock Option to the extent the aggregate Fair Market Value, determined at the time the Administrator grants the Incentive Stock Option and any
Corresponding SAR, of shares of Common Stock with respect to which a Participant may exercise Incentive Stock Options or Corresponding SARs for the first time during any calendar year under this Plan
and any other plan of the Company (or any plan of any parent or Subsidiary of the Company) exceeds $100,000. If the limitation is exceeded, the Incentive Stock Options that cause the limitation to be
exceeded shall be treated as Nonqualified Stock Options. 

        7.04.     Restrictions on Ten-Percent Shareholders.    No Employee may receive an Incentive
Stock Option under the Plan if such Employee, at the time of grant, is a Ten Percent Shareholder, unless the Option price per share for such Incentive Stock Option is at least 110 percent of
the Fair Market Value on the date of grant of each share of Common Stock subject to such Incentive Stock Option and unless such Incentive Stock Option is not exercisable after the expiration of five
years from the date such Incentive Stock Option is granted. 

        7.05.     Validity of Options.    Options that are intended to be Incentive Stock Options but do not
qualify as such shall be treated as Nonqualified Stock Options. 

        7.06.     Notification Upon Sale.    A Participant shall give written notice to the Company if the
Participant sells or otherwise disposes of any shares of Common Stock acquired under an Incentive Stock Option before the expiration of the later of the two-year period beginning on the
date of grant of the Incentive Stock Option or the one-year period beginning on the date that the Participant exercises the Incentive Stock Option with respect to such shares of Common
Stock. 

        7.07.     No Liability of Company.    The Company shall not be liable to any Participant or any other
person if the Internal Revenue Service or any court having jurisdiction over such matter determines for any reason that any Option intended to be an Incentive Stock Option and granted hereunder does
not qualify as an Incentive Stock Option. 

 
 

ARTICLE VIII
  TERMS AND CONDITIONS OF RESTRICTED STOCK    
    

        8.01.     Grants.    In accordance with the provisions of Article IV, the Administrator will
designate each individual to whom Restricted Stock is to be granted or sold and will specify the number of shares of Common Stock such Award covers and the purchase price, if any, the Participant must
pay for any 

9

 

Award.
The date Restricted Stock is granted shall be the date on which the Administrator has approved the terms and conditions of the Restricted Stock grant. If the Participant must pay for an Award,
the date of grant shall not be earlier than the date the Participant pays for the Restricted Stock in accordance with Section 8.02. Restricted Stock shall be evidenced by an Agreement in such
form and containing such terms, conditions and restrictions (not inconsistent with the Plan) as the Administrator in its sole discretion determines. 

        8.02.     Payment.    Unless the Agreement provides otherwise, if the Participant must pay for an Award
of Restricted Stock, payment of the Award shall be made in cash or cash equivalent acceptable to the Administrator. If the Agreement so provides, the Administrator in its discretion and provided
applicable law so permits, may allow a Participant to pay all or part of the purchase price (i) by surrendering shares of Common Stock to the Company that the Participant has held for at least
six months; (ii) by such other medium of payment as the Administrator in its discretion shall authorize or (iii) by any combination of the aforementioned methods of payment. If Common
Stock is used to pay all or part of the purchase price, the sum of the cash and cash equivalent and other payments and the Fair Market Value (determined as of the day preceding the date of purchase)
of the Common Stock surrendered must not be less than the purchase price of the Restricted Stock. 

        8.03.     Maximum Vesting Period.    The Administrator on the date of grant shall determine the maximum
period over which Restricted Stock may become Vested, except that no Restricted Stock shall become Vested after the expiration of 10 years from the date such Restricted Stock is granted. The
terms of any Restricted Stock may provide that such Restricted Stock will become Vested over a period less than such maximum period. 

        8.04.     Nontransferability.

        (a)   Except
as set forth in Section 8.04(b) below, Restricted Stock granted under the Plan shall be nontransferable except by will or by the laws of descent and
distribution, until it has become Vested. In the event of any such transfer of Restricted Stock, the Restricted Stock must be transferred in its entirety to the same person or persons or entity or
entities. Except as set forth in Section 8.04(b) below, during the lifetime of the Participant to whom the Restricted Stock is granted, only the Participant may become Vested in the Restricted
Stock. No Restricted Stock or any right or interest of a Participant in any shares of Restricted Stock shall be liable for, or subject to, any liability, lien or obligation of such Participant. 

        (b)   Notwithstanding
Section 8.04(a) above, if the applicable Agreement so provides, Restricted Stock may be transferred by the Participant to a Permitted Transferee.
Any such transfer will be permitted only if (i) the Participant does not receive any consideration for the transfer and (ii) the Administrator expressly approves the transfer. The
Permitted Transferee shall be bound by the same terms and conditions that governed the Restricted Stock during the period the Participant held it; provided, however, that such Permitted Transferee may
not transfer such Restricted Stock except by will or the laws of descent and distribution. Any such transfer shall be evidenced by an appropriate written document executed by the Participant, and a
copy thereof shall be delivered to the Administrator on or prior to the effective date of the transfer. 

        8.05.     Change in Control.    Notwithstanding any provision of any Agreement, in the event of or in
anticipation of a Change in Control, the Administrator in its discretion may terminate on or after an Acceleration Date or before or on the Control Change Date outstanding shares of Restricted Stock
previously granted under the Plan that are not then Vested without any payment to the holder of the Restricted Stock. The Administrator in its discretion may take the action described in this
Section 8.05 contingent on the consummation of the Change in Control and with respect to some or all outstanding shares of Restricted Stock or on a share-by-share basis,
which actions need not be uniform with respect to all outstanding shares of Restricted Stock. The preceding sentences to the contrary notwithstanding, the shares of Restricted Stock shall not be
terminated to the extent that written provision is made for 

10

 

their
assumption, continuance or substitution by a successor employer or its parent or subsidiary in connection with the Change in Control. 

        8.06.     Vesting.    The Administrator in its discretion may but need not declare that some or all
outstanding shares of Restricted Stock previously granted under the Plan shall become Vested, in whole or in part, on or after an Acceleration Date or before or on the Control Change Date. The
Administrator may act with respect to some or all outstanding shares of Restricted Stock or on a share-by-share basis, which actions need not be uniform with respect to
outstanding shares of Restricted Stock. Subject to the preceding sentences, shares of Restricted Stock acquired under the Plan shall become Vested in whole at any time or in part from time to time at
such times and in compliance with such requirements as the Administrator shall determine and set forth in the Agreement. If and to the extent deemed necessary by the Administrator, shares of
Restricted Stock granted to Named Executive Officers shall become Vested subject to performance objectives that enable such Restricted Stock to qualify as "performance based compensation" under the
Treasury Regulations promulgated under Code Section 162(m). The grant of Restricted Stock can only become Vested during the Participant's lifetime in the hands of the Participant. 

        8.07.     Shareholder Rights.    Before the shares of Restricted Stock become Vested, the Participant
will have all rights of a shareholder in the shares of Restricted Stock as provided under the Certificate of Incorporation of the Company and applicable law, including without limitation the right to
vote the shares and receive dividends and distributions thereon; provided, however, that during such period the Participant (i) may not sell, transfer, exchange, pledge, hypothecate or
otherwise dispose of any shares of Restricted Stock; (ii) the Company shall retain custody of the certificates evidencing the shares of Restricted Stock until they become Vested and
(iii) the Participant will deliver to the Company a stock power, endorsed in blank, with respect to each share of Restricted Stock. The Company may include on any certificates representing
shares of Common Stock issued pursuant to a grant of Restricted Stock such legends referring to any representations, restrictions or other applicable statements as the Company, in its discretion,
shall deem appropriate. 

 
 

ARTICLE IX
  TERMS AND CONDITIONS OF RESTRICTED STOCK UNITS    
    

        9.01.     Grants.    In accordance with the provisions of Article IV, the Administrator will
designate each individual to whom Restricted Stock Units are to be granted and will specify the number of Restricted Stock Units such grant covers. All Restricted Stock Units shall be evidenced by an
Agreement in such form and containing such terms, conditions and restrictions (not inconsistent with the Plan) as the Administrator in its sole discretion determines. 

        9.02.     Maximum Payment Period.    The Administrator on the date of grant shall determine the maximum
period over which Restricted Stock Units may become payable, except that no Restricted Stock Unit shall become payable after the expiration of 10 years from the date such Restricted Stock Unit
is granted. The terms of any Restricted Stock Unit may provide that it is payable for a period less than such maximum period. 

        9.03.     Nontransferability.

        (a)   Except
as set forth in Section 9.03(b) below, Restricted Stock Units granted under the Plan shall be nontransferable except by will or by the laws of descent and
distribution, until they have become Vested. In the event of any such transfer of Restricted Stock Units, the Restricted Stock Units must be transferred in their entirety to the same person or persons
or entity or entities. Except as set forth in Section 9.03(b) below, during the lifetime of the Participant to whom the Restricted Stock Units are granted, only the Participant may become
Vested in the Restricted Stock Units. No Restricted Stock Units or any right or interest of a Participant in any Restricted Stock Units shall be liable for, or subject to, any liability, lien or
obligation of such Participant. 

11

 

        (b)   Notwithstanding
Section 9.03(a) above, if the applicable Agreement so provides, Restricted Stock Units may be transferred by the Participant to a Permitted
Transferee. Any such transfer will be permitted only if (i) the Participant does not receive any consideration for the transfer and (ii) the Administrator expressly approves the
transfer. The Permitted Transferee shall be bound by the same terms and conditions that governed the Restricted Stock Units during the period the Participant held them; provided, however, that such
Permitted Transferee may not transfer such Restricted Stock Units except by will or the laws of descent and distribution. Any such transfer shall be evidenced by an appropriate written document
executed by the Participant, and a copy thereof shall be delivered to the Administrator on or prior to the effective date of the transfer. 

        9.04.     Change in Control.    Notwithstanding any provision of any Agreement, in the event of or in
anticipation of a Change in Control, the Administrator in its discretion may terminate on or after an Acceleration Date or before or on the Control Change Date some or all outstanding Restricted Stock
Units previously granted under the Plan that are not then payable without any payment to the holder of the Restricted Stock Units. The Administrator in its discretion may take the action described in
this Section 9.04 contingent on consummation of the Change in Control and with respect to some or all outstanding Restricted Stock Units or on a Restricted Stock
Unit-by-Restricted Stock Unit basis, which actions need not be uniform with respect to all outstanding Restricted Stock Units. The Restricted Stock Units shall not be
terminated to the extent that written provision is made for their assumption, continuance or substitution by a successor employer or its parent or subsidiary in connection with the Change in Control. 

        9.05.     Right to Receive Payment.    The Administrator in its discretion may but need not declare that
some or all outstanding Restricted Stock Units granted under the Plan shall become payable, in whole or in part, on or after an Acceleration Date or before or on the Control Change Date. The
Administrator may act with respect to some or all outstanding Restricted Stock Units or on a Restricted Stock Unit-by-Restricted Stock Unit basis, which actions need not be
uniform with respect to all outstanding Restricted Stock Units. Subject to the preceding sentences, Restricted Stock Units may be paid in whole at any time or in part from time to time at such times
and in compliance with such requirements as the Administrator shall determine and set forth in the Agreement. If and to the extent deemed necessary by the Administrator, Restricted Stock Units granted
to Named Executive Officers shall become payable subject to performance objectives that enable such Restricted Stock Units to qualify as "performance based compensation" under the Treasury Regulations
promulgated under Code Section 162(m). The payment of one or more Restricted Stock Units shall not affect the right to receive payment for any remaining Restricted Stock Units. 

        9.06.     Form of Payment.    The Company shall pay each Participant one share of Common Stock for each
Restricted Stock Unit that becomes payable and shall deliver to the Participant (or the Participant's broker if the Participant so directs) certificates representing the shares of Common Stock that
have been paid. 

        9.07.     Shareholder Rights.    No Participant shall have any rights as a shareholder with respect to
any Restricted Stock Units until the Participant receives payment of such Restricted Stock Units as described in Section 9.06 and the issuance to the Participant of the certificates
representing the shares of Common Stock that have been paid. The Company may include on any certificates representing shares of Common Stock issued pursuant to a grant of Restricted Stock such legends
referring to any representations, restrictions or other applicable statements as the Company, in its discretion, shall deem appropriate. However, notwithstanding the foregoing, the Administrator in
its sole discretion may set forth in the Agreement that, for so long as the Participant holds any Restricted Stock Units, if the Company pays any cash dividends on its Common Stock, then
(a) the Company may pay the Participant in cash for each outstanding Restricted Stock Unit covered by the Agreement as of the record date of such dividend, less than any required withholdings,
the per share amount of such dividend or (b) the number of outstanding Restricted Stock Units covered by the Agreement may be 

12

 

increased
by the number of Restricted Stock Units, rounded down to the nearest whole number, equal to (i) the product of the number of the Participant's outstanding Restricted Stock Units as of
the record date for such dividend multiplied by the per share amount of the dividend divided by (ii) the fair market value of a share of Common Stock on the payment date of such dividend. In
the event additional Restricted Stock Units are awarded, such Restricted Stock Units shall be subject to the same terms and conditions set forth in the Plan and the Agreement as the outstanding
Restricted Stock Units with respect to which they were granted. 

 
 

ARTICLE X
  TERMS AND CONDITIONS OF SARS    
    

        10.01.     Grants.    In accordance with the provisions of Article IV, the Administrator will
designate each individual to whom a SAR is to be granted and will specify the number of shares of Common Stock encompassed by such grant and whether the SAR is a Corresponding SAR. The date a SAR is
granted shall be the date on which the Administrator has approved the terms and conditions of the SAR. Each SAR granted under the Plan shall be evidenced by an Agreement in such form and containing
such terms, conditions and restrictions (not inconsistent with this Plan) as the Administrator in its sole discretion determines. 

        10.02.     Maximum SAR Period.    The Administrator on the date of grant shall determine the maximum
period in which a SAR may be exercised, except that no SAR shall be exercisable after the expiration of 10 years from the date the SAR is granted. The terms of a SAR may provide that it is
exercisable for a period less than such maximum period. No Corresponding SAR shall be exercisable or continue in existence after the expiration of the Option to which the Corresponding SAR relates. 

        10.03.     Nontransferability.

        (a)   Except
as set forth in Section 10.03(b) below, each SAR granted under this Plan shall be nontransferable except by will or by the laws of descent and
distribution. In the event of any transfer of a Corresponding SAR, the Corresponding SAR and the Option to which it relates must be transferred in their entirety to the same persons or entities.
Except as set forth in Section 10.03(b) below, during the lifetime of the Participant to whom the SAR is granted, only the Participant may exercise the SAR. No right or interest of a
Participant in any SAR shall be liable for, or subject to, any liability, lien or obligation of such Participant. 

        (b)   Notwithstanding
Section 10.03(a) above, if the applicable Agreement so provides, a SAR (other than a Corresponding SAR that is related to an Incentive Stock
Option) may be transferred by the Participant to a Permitted Transferee. Any such transfer will be permitted only if (i) the Participant does not receive any consideration for the transfer and
(ii) the Administrator expressly approves the transfer. The Permitted Transferee shall be bound by the same terms and conditions that governed the SAR during the period the Participant held it;
provided, however, that such Permitted Transferee may not transfer such SAR except by will or the laws of descent and distribution. Any such transfer shall be evidenced by an appropriate written
document executed by the Participant, and a copy thereof shall be delivered to the Administrator on or prior to the effective date of the transfer. In the event of a transfer of a Corresponding SAR
pursuant to this Section 10.03(b), the Corresponding SAR and the related Option must be transferred to the same transferee. 

        10.04.     Change in Control.    Notwithstanding any provision of any Agreement, in the event of or in
anticipation of a Change in Control, the Administrator in its discretion (i) may declare that some or all outstanding SARs previously granted under the Plan, whether or not then exercisable,
shall terminate as of a date on or after an Acceleration Date or before or on the Control Change Date without any payment to the holder of the SAR, provided the Administrator gives prior written
notice to the Participants of such termination and gives such Participants the right to exercise their outstanding SARs at least 15 days before such termination date to the extent then
exercisable or (ii) may terminate on or 

13

 

after
an Acceleration Date or before or on the Control Change Date some or all outstanding SARs previously granted under the Plan, whether or not then exercisable, in consideration of payment to the
holder of the SAR, with respect to each share of Common Stock for which the SAR is then exercisable, of the excess, if any, of the Fair Market Value of such Common Stock on such date over the Initial
Value of the SAR. The payment described in (ii) above may be made in any manner the Administrator determines, including in cash, Voting Stock or other property. The Administrator may take the
actions described in (i) or (ii) above with respect to SARs that are not then exercisable whether or not the Participant will receive any payment therefor. The Administrator in its
discretion may take the actions described in (i) or (ii) above contingent on consummation of the Change in Control and with respect to some or all outstanding SARs, whether or not then
exercisable, or on a SAR-by-SAR basis, which actions need not be uniform with respect to all outstanding SARs. Notwithstanding the foregoing, no payment shall be made with
respect to a Corresponding SAR to the extent the Administrator made a payment with respect to the Option that relates to the Corresponding SAR. No SARs shall be terminated to the extent that written
provision is made for their assumption, continuance or substitution by a successor employer or its parent or subsidiary in connection with the Change in Control. 

        10.05.     Exercise.    The Administrator in its discretion may but need not declare that some or all
outstanding SARs previously granted under the Plan shall be exercisable, in whole or in part, on the earlier of (i) immediately before the time the Administrator takes either of the actions
described in (i) or (ii) of Section 10.04 above or (ii) as of the Control Change Date; if the Administrator makes such declaration, all such SARs which became exercisable
shall remain exercisable thereafter in accordance with the terms of the Plan and the applicable Agreement. The Administrator may act with respect to some or all outstanding SARs or on a
SAR-by-SAR basis, which actions need not be uniform with respect to all outstanding SARs. Subject to the preceding sentences, a SAR may be exercised in whole at any time or in
part from time to time at such times and in compliance with such requirements as the Administrator shall determine and as set forth in this Plan and the applicable Agreement. A SAR granted under this
Plan may be exercised with respect to any number of whole shares less than the full number of shares covered by the SAR. A partial exercise of a SAR shall not affect the right to exercise the SAR from
time to time in accordance with this Plan and the applicable Agreement with respect to the remaining shares covered by the SAR. A SAR may be exercised and paid only to the extent that the Fair Market
Value of the Common Stock that is the subject of the exercise exceeds the Initial Value of the SAR. 

        10.06.     Special Rules for Corresponding SARs.    Upon the exercise or payment of a Corresponding SAR,
the Participant shall surrender to the Company, unexercised and unpaid, any portion of an Option to which the Corresponding SAR relates. Upon exercise or payment of an Option to which a Corresponding
SAR relates, the Participant shall surrender to the Company, unexercised and unpaid, the related portion of the Corresponding SAR. A Corresponding SAR may be exercised only to the extent that the
related Option is exercisable. 

        10.07.     Payment Upon Exercise of SAR.    Within 15 days after the exercise of a SAR, the
Company shall pay the Participant, with respect to each share of Common Stock encompassed by the exercise of the SAR, the excess of the Fair Market Value of such Common Stock on the date of exercise
over the Initial Value. The Administrator, in its discretion, shall determine and set forth in the applicable Agreement whether the amount payable as a result of the exercise of a SAR will be paid
(i) in cash; (ii) Common Stock; (iii) by delivery of the Company's or any Subsidiary's full recourse, interest-bearing promissory note, bearing interest at such rate as would
avoid interest being imputed under the Code or (iv) by any combination of the foregoing. 

        10.08.     Shareholder Rights.    No Participant shall have any rights as a shareholder with respect to
shares of Common Stock subject to a SAR until the proper exercise of the SAR, and then only to the extent that Common Stock is issued to the Participant. The Company may include on any certificates 

14

 

representing
shares of Common Stock issued pursuant to a SAR such legends referring to any representations, restrictions or any other applicable statements as the Company, in its discretion, shall
deem appropriate. 

 
 

ARTICLE XI
  TERMS AND CONDITIONS OF PERFORMANCE AWARDS    
    

        11.01.     Grants.    In accordance with the provisions of Article IV, the Administrator will
designate each individual to whom a Performance Award is to be granted and will specify the terms and conditions applicable to such Performance Award, including the performance objectives the
Participant must satisfy to receive a payment under the Performance Award. The date a Performance Award is granted shall be the date on which the Administrator has approved the terms and conditions of
the Performance Award. Each Performance Award granted under the Plan shall be evidenced by an Agreement in such form and containing such terms, conditions and restrictions (not inconsistent with this
Plan) as the Administrator in its sole discretion determines. 

        11.02.     Maximum Performance Award Period.    The Administrator on the date of grant shall determine
the maximum period in which a Performance Award may be paid, except that no Performance Award may be paid after the expiration of 10 years from the date such Performance Award is granted. The
terms of any Performance Award may provide that it can be paid over a period less than such maximum period. 

        11.03.     Nontransferability.

        (a)   Except
as set forth in Section 11.03(b) below, Performance Awards granted under this Plan shall be nontransferable except by will or by the laws of descent and
distribution, until they have become payable. In the event of any such transfer of Performance Awards, the Performance Award must be transferred in their entirety to the same person or persons or
entity or entities. Except as set forth in Section 11.03(b) below, during the lifetime of the Participant to whom the Performance Awards are granted, the Performance Awards may only become
payable to the Participant. No Performance Awards or any right or interest of a Participant in any Performance Awards shall be liable for, or subject to, any liability, lien or obligation of such
Participant. 

        (b)   Notwithstanding
Section 11.03(a) above, if the applicable Agreement so provides, Performance Awards may be transferred by the Participant to a Permitted
Transferee. Any such transfer will be permitted only if (i) the Participant does not receive any consideration for the transfer and (ii) the Administrator expressly approves the
transfer. The Permitted Transferee of such Performance Awards shall be bound by the same terms and conditions that governed the Performance Awards during the period the Participant held them;
provided, however, that such Permitted Transferee may not transfer such Performance Awards except by will or the laws of descent and distribution. Any such transfer shall be evidenced by an
appropriate written document executed by the Participant, and a copy thereof shall be delivered to the Administrator on or prior to the effective date of the transfer. 

15

  

        11.04.     Change in Control.    Notwithstanding any provision of any Agreement, in the event of or in
anticipation of a Change in Control, the Administrator in its discretion may terminate on or after an Acceleration Date or before or on the Control Change Date some or all outstanding Performance
Awards previously granted under the Plan that are not then payable without any payment to the holder of the Performance Award. The Administrator in its discretion may take the action described in this
Section 11.03 contingent on consummation of the Change in Control and with respect to some or all outstanding Performance Awards or on a Performance Award-by-Performance
Award basis, which actions need not be uniform with respect to all outstanding Performance Awards. The Performance Awards shall not be terminated to the extent that written provision is made for their
assumption, continuance or substitution by a successor employer or its parent or subsidiary in connection with the Change in Control. 

        11.05.     Payment of Performance Award.    The Administrator in its discretion may but need not declare
that some or all outstanding Performance Awards granted under the Plan shall become payable, in whole or in part, on or after an Acceleration Date or before or on a Control Change Date. The
Administrator may act with respect to some or all outstanding Performance Awards or on a Performance Award-by-Performance Award basis, which actions need not be uniform with
respect to all outstanding Performance Awards. Subject to the preceding sentences, a Performance Award will become payable at such times, in such amounts and in compliance with such requirements as
the Administrator shall determine and as set forth in this Plan and the applicable Agreement. If and to the extent deemed necessary by the Administrator, Performance Awards granted to Named Executive
Officers shall become payable pursuant to performance objectives that enable the Performance Award to qualify as "performance based compensation" under the Treasury Regulations promulgated under Code
Section 162(m). 

        11.06.     Shareholder Rights.    No Participant shall have any rights as a shareholder with respect to
any Performance Award until payment of the Performance Award and then only to the extent that payment is made in Common Stock that is issued to the Participant. The Company may include on any
certificates representing shares of Common Stock issued pursuant to a Performance Award such legends referring to any representations, restrictions or any other applicable statements as the Company,
in its discretion, shall deem appropriate. 

 
 

ARTICLE XII
  ADDITIONAL TERMS AND CONDITIONS APPLICABLE TO ALL AWARDS    
    

        12.01.     Interruption of Employee or Independent Contractor Status.    In the event that the terms of
any Award provide that it may be exercised, Vested or paid only during employment or service or within a specified period of time after termination of employment or service, the Administrator may
decide to what extent leaves of absence for illness, temporary disability, governmental or military service or other reasons shall not be deemed interruptions of employment or service. 

        12.02.     Performance Objectives.    The Administrator may prescribe that an Award may be exercised,
Vested or paid only to the extent that certain performance objectives are obtained. Such performance objectives may be based on one or more of the Company's or any Subsidiary's or any division's
(i) gross, operating or net earnings before or after taxes; (ii) return on equity; (iii) return on capital; (iv) return on sales; (v) return on assets or net assets;
(vi) earnings per share; (vii) cash flow per share; (viii) book value per share; (ix) earnings growth; (x) sales growth; (xi) customer growth;
(xii) cash flow (as the Administrator may define such term); (xiii) Fair Market Value of the Company or any Subsidiary or shares of Common Stock; (xiv) share price or total
shareholder return; (xv) market share; (xvi) economic value added; (xvii) market value added; (xviii) productivity; (xix) level of expenses; (xx) quality;
(xxi) safety; (xxii) customer satisfaction or (xxiii) peer group comparisons of any of the aforementioned performance objectives. If the Administrator, on the grant of the Award,
prescribes that the Award shall be exercisable or shall become Vested or payable only upon the 

16

 

attainment
of performance objectives stated with respect to one or more of the foregoing criteria, the Award shall become exercisable, Vested or payable only to the extent the Administrator certifies
in writing that such performance objectives have been obtained. Additionally, the Administrator may prescribe that an Award may be exercised, Vested, or paid only to the extent that the Participant
completes a specified period of employment or service with the Company or any Subsidiary. 

        12.03.     Other Conditions.    The Administrator, in its discretion, may, as a condition to the grant of
an Award, require the Participant on or before the date of grant of the Award to enter into (i) a covenant not to compete (including a confidentiality, non-solicitation or other
similar agreement) with the Company or any Subsidiary, which shall become effective on the date of termination of employment or service of the Participant with the Company or any Subsidiary or any
other date the Administrator may specify and shall contain such terms and conditions as the Administrator shall otherwise specify and/or (ii) an agreement to cancel any other employment
agreement, service agreement, fringe benefit or compensation arrangement in effect between the Company or any Subsidiary and such Participant. If the Participant shall fail to enter into any such
agreement at the Administrator's request, then no Award shall be granted to the Participant and the number of shares of Common Stock that would have been subject to such Award, if any, shall be added
to the remaining shares of Common Stock available under the Plan. 

        12.04.     Forfeiture Provisions.    Notwithstanding any other provisions of the Plan or any Agreement,
all rights to any Award that a Participant has will be immediately discontinued and forfeited, and the Company shall not have any further obligation hereunder to the Participant with respect to any
Award and the Award will not be exercisable (whether or not previously exercisable) or become Vested or payable on and after the time the Participant is discharged from employment or service with the
Company or any Subsidiary for Cause. 

 
 

ARTICLE XIII
  DEFERRED BENEFITS    
    

        In accordance with rules the Administrator prescribes, a Participant who is eligible for the Deferred Compensation Program may elect to defer the receipt of
Common Stock issuable or cash or other consideration payable to the Participant pursuant to any Award. The Administrator in its discretion may prescribe the types of Awards that are subject to the
Deferred Compensation Program, the Participants eligible to participate in the Deferred Compensation Program and all other administrative rules relating thereto relating to Awards. 

 
 

ARTICLE XIV
  LIMITATION ON BENEFITS    
    

        Despite any other provisions of this Plan to the contrary, if the receipt of any payments or benefits under this Plan would subject a Participant to tax under
Code Section 4999, the Administrator may determine whether some amount of payments would meet the definition of a "Reduced Amount." If the Administrator determines that there is a Reduced
Amount, the total payments to the Participant hereunder must be reduced to such Reduced Amount, but not below zero. If the Administrator determines that the benefits and payments must be reduced to
the Reduced Amount, the Company must promptly notify the Participant of that determination, with a copy of the detailed calculations by the Administrator. All determinations of the Administrator under
this Article XIV are final, conclusive and binding upon the Company and the Participant. It is the intention of the Company and the Participant to reduce the payments under this Plan only if
the aggregate Net After Tax Receipts to the Participant would thereby be increased. As result of the uncertainty in the application of Code Section 4999 at the time of the initial determination
by the Administrator under this Article XIV, however, it is possible that amounts will have been paid under the Plan to or for the benefit of a Participant which should not have been so paid
("Overpayment") or that additional amounts which will 

17

 

not
have been paid under the Plan to or for the benefit of a Participant could have been so paid ("Underpayment")—in each case, consistent with the calculation of the Reduced Amount. If
the Administrator, based either upon the assertion of a deficiency by the Internal Revenue Service against the Company or the Participant which the Administrator believes has a high probability of
success or controlling precedent or other substantial authority, determines that an Overpayment has been made, any such Overpayment must be treated for all purposes as a loan which the Participant
must repay to the Company together with interest at the applicable federal rate under Code Section 7872(f)(2); provided, however, that no such loan may be deemed to have been made and no amount
shall be payable by the Participant to the Company if and to the extent such deemed loan and payment would not either reduce the amount on which the Participant is subject to tax under Code
Section 1, 3101 or 4999 or generate a refund of such taxes. If the Administrator, based upon controlling precedent or other substantial authority, determines that an Underpayment has occurred,
the Administrator must promptly notify the Company of the amount of the Underpayment, which then shall be paid to the Participant. For purposes of this Section, (i) "Net After Tax Receipt"
means the Present Value of a payment under this Plan net of all taxes imposed on Participant with respect thereto under Code Sections 1, 3101 and 4999, determined by applying the highest marginal rate
under Code Section 1 which applies to the Participant's taxable income for the applicable taxable year; (ii) "Present Value" means the value determined in accordance with Code
Section 280G(d)(4) and (iii) "Reduced Amount" means the smallest aggregate amount of all payments under this Plan which (a) is less than the sum of all payments under this Plan
and (b) results in aggregate Net After Tax Receipts which are equal to or greater than the Net After Tax Receipts which would result if the aggregate payments under this Plan were any other
amount less than the sum of all payments to be made under this Plan. 

 
 

ARTICLE XV
  ADJUSTMENT UPON CHANGE IN COMMON STOCK    
    

        The maximum number of shares as to which Awards and Deferred Stock Benefits may be granted under this Plan, the terms of outstanding Awards and Deferred Stock
Benefits, the per individual limitations on the number of shares for which Awards may be granted and any other limitations in this Plan shall be adjusted as the Administrator shall determine to be
equitably required in the event that (a) the Company (i) effects one or more stock dividends, stock split-ups, subdivisions or consolidations of shares or (ii) engages
in a transaction to which Code Section 424 or any similar event applies or (b) there occurs any other event which, in the judgment of the Administrator, necessitates such action. In
addition, the Administrator may make such other adjustments to the terms of an outstanding Award or Deferred Stock Benefit to the extent equitable and necessary to prevent an enlargement or dilution
of the Participant's rights thereunder as a result of any such event or similar transaction. Any determination the Administrator makes under this Article XV shall be final and conclusive. The
issuance by the Company of either shares of stock of any class or securities convertible into shares of stock of any class, for cash or property, or for labor or services, either upon direct sale or
upon the exercise of rights or warrants to subscribe therefor, or upon conversion of shares or obligations of the Company convertible into such shares or other securities, shall not affect, and no
adjustment by reason thereof shall be made with respect to, the maximum number of shares as to which Awards and Deferred Stock Benefits may be granted, the per individual limitations on the number of
shares for which Awards may be granted, any other limitations in this Plan or the terms of outstanding Awards and Deferred Stock Benefits. The Administrator may grant Awards in substitution for
performance shares, stock awards, stock options, stock appreciation rights, phantom shares, or similar awards held by an individual who becomes an Employee, contractor, agent or other service provider
of the Company in connection with a transaction described in the first paragraph of this Article XV. Notwithstanding any provision of the Plan (other than the limitations of Article V),
the terms of such substituted Awards shall be as the Administrator, in its discretion, determines is appropriate. 

18

 

 
 

ARTICLE XVI
  COMPLIANCE WITH LAW AND APPROVAL OF REGULATORY BODIES    
    

        16.01.     Compliance.    No Award shall be granted or become exercisable, Vested or payable, no Common
Stock shall be issued, no certificates for shares of Common Stock shall be delivered, and no payment shall be made except in compliance with all applicable federal and state laws and regulations
(including, without limitation, withholding tax requirements), any listing agreement with any stock exchange to which the Company is a party, and the rules of all domestic stock exchanges on
which the Company's shares may be listed. The Company shall have the right to rely on an opinion of its counsel as to such compliance. Any certificate for shares of Common Stock issued under the Plan
may bear such legends and statements as the Administrator may deem advisable to assure compliance with federal and state laws and regulations. No Award will be granted, become exercisable, Vested or
payable, no Common Stock shall be issued, no certificate for shares of Common Stock shall be delivered, and no payment shall be made under this Plan until the Company has obtained such consent or
approval as the Administrator may deem advisable from regulatory bodies having jurisdiction over such matters. 

        16.02.     Postponement of Exercise or Payment.    The Administrator may postpone any grant, exercise,
Vesting or payment of an Award for such time as the Administrator in its sole discretion may deem necessary in order to permit the Company (i) to effect, amend or maintain any necessary
registration of the Plan or the shares of Common Stock issuable pursuant to the Award under the securities laws; (ii) to permit any action to be taken in order to (A) list such shares of
Common Stock or other shares of stock of the Company on a stock exchange if shares of Common Stock or other shares of stock of the Company are not then listed on such exchange or (B) comply
with restrictions or regulations incident to the maintenance of a public market for its shares of Common Stock or other shares of stock of the Company, including any rules or regulations of any stock
exchange on which the shares of Common Stock or other shares of stock of the Company are listed; (iii) to determine that such shares of Common Stock in the Plan are exempt from such
registration or that no action of the kind referred to in (ii)(B) above needs to be taken; (iv) to comply with any other applicable law, including without limitation, securities laws;
(v) during any such time the Company or any Subsidiary is prohibited from doing any of such acts under applicable law, including without limitation, during the course of an investigation of the
Company or any Subsidiary, or under any contract, loan agreement or covenant or other agreement to which the Company or any Subsidiary is a party or (vi) to otherwise comply with any
prohibition on such acts or payments during any applicable blackout period; and the Company shall not be obligated by virtue of any terms and conditions of any Agreement or any provision of the Plan
to recognize the grant, exercise, Vesting or payment of an Award or to grant, sell or issue shares of Common Stock or make any such payments in violation of the securities laws or the laws of any
government having jurisdiction thereof or any of the provisions hereof. Any such postponement shall not extend the term of the Award and neither the Company nor its directors and officers nor the
Administrator shall have any obligation or liability to any Participant or to any other person with respect to shares of Common Stock or payments as to which the Award shall lapse because of such
postponement. 

        16.03.     Forfeiture of Payment.    The Participant shall be required to forfeit any and all rights
under Awards or to reimburse the Company for any payment under any Award (with interest as necessary to avoid imputed interest or original issue discount under the Code or as otherwise required by
applicable law) to the extent applicable law requires such forfeiture or reimbursement, including without limitation, in connection with any event where the Company or any Subsidiary is required to
prepare an accounting restatement due to material noncompliance, as a result of misconduct with financial reporting requirements, for any applicable period. 

19

 

 
 

ARTICLE XVII
  GENERAL PROVISIONS    
    

        17.01.     Effect on Employment and Service.    Neither the adoption of this Plan, its operation, nor any
Agreement or other documents describing or referring to this Plan shall confer upon any individual any right to continue in the employ or service of the Company or any Subsidiary or in any way affect
the right and power of the Company or any Subsidiary to terminate the employment or service of any individual at any time with or without assigning a reason therefor. 

        17.02.     Unfunded Plan.    The Plan shall be unfunded, and the Company shall not be required to
segregate any assets that may at any time be represented by Awards under this Plan. Any liability of the Company to any person with respect to any Award under this Plan shall be based solely upon any
contractual obligations that may be created pursuant to this Plan. No such obligation of the Company shall be deemed to be secured by any pledge of, or other encumbrance on, any property of the
Company. 

        17.03.     Tax Withholding and Reporting.    Unless an Agreement provides otherwise, each Participant
shall be responsible for satisfying in cash or cash equivalent acceptable to the Administrator any income and employment (including without limitation Social Security and Medicare) tax withholding
obligations attributable to participation in the Plan and the grant, exercise, Vesting or payment of Awards granted thereunder. In accordance with procedures that the Administrator establishes, the
Administrator, to the extent applicable law permits, may allow a Participant to pay such amounts (i) by surrendering shares of Common Stock that the Participant has held for at least six months
(but only for the minimum required withholding); (ii) by a cashless exercise through a broker; (iii) by such other medium of payment as the Administrator in its discretion shall
authorize or (iv) by any combination of the aforementioned methods of payment. The Company shall comply with all such reporting and other requirements relating to the administration of this
Plan and the grant, exercise, Vesting or payment of any Award hereunder as applicable law requires. 

        17.04.     Reservation of Shares.    The Company, during the term of this Plan, shall at all times
reserve and keep available such number of shares of Common Stock as shall be sufficient to satisfy the requirements of the Plan. Additionally, the Company, during the term of this Plan, shall use its
best efforts to seek to obtain from appropriate regulatory agencies any requisite authorizations needed in order to issue and to sell such number of shares of Common Stock as shall be sufficient to
satisfy the requirements of the Plan. However, the inability of the Company to obtain from any such regulatory agency the requisite authorizations the Company's counsel deems to be necessary for the
lawful issuance and sale of any shares of Common Stock hereunder, or the inability of the Company to confirm to its satisfaction that any issuance and sale of any shares of Common Stock hereunder will
meet applicable legal requirements, shall relieve the Company of any liability in respect to the failure to issue or to sell such shares of Common Stock as to which such requisite authority shall not
have been obtained. 

        17.05.     Governing Law.    This Plan and all Awards granted hereunder shall be governed by the laws of
the State of Delaware, except to the extent federal law applies. 

        17.06.     Other Actions.    Nothing in the Plan shall be construed to limit the authority of the Company
to exercise its corporate rights and powers, including, by way of illustration and not by way of limitation, the right to grant options, restricted stock, restricted stock units, stock appreciation
rights or performance awards for proper corporate purposes otherwise than under the Plan to any employee or to any other person, firm, corporation, association or other entity, or to grant options,
restricted stock, restricted stock units, stock appreciation rights or performance awards to, or assume such awards of any person in connection with, the acquisition, purchase, lease, merger,
consolidation, reorganization or otherwise, of all or any part of the business and assets of any person, firm, corporation, association or other entity. 

20

 

 
 

ARTICLE XVIII
  AMENDMENT    
    

        The Board may amend this Plan from time to time or terminate the Plan; provided, however, that no amendment may become effective until shareholder approval is
obtained if (i) the amendment increases the aggregate number of shares of Common Stock that may be issued pursuant to Awards under the Plan; (ii) the amendment changes the class of
individuals eligible to receive Awards or (iii) the amendment changes the performance objectives to which the exercisability, Vesting or payment of Awards granted to Named Executive Officers
may be subject. No amendment shall, without a Participant's consent, adversely affect any rights of such Participant under any outstanding Award at the time such amendment is made. No amendment shall,
without the consent of a participant in the Deferred Compensation Program, adversely affect any rights of such participant under the Deferred Compensation Program as in effect at that time.
Notwithstanding the foregoing, the Plan may not be terminated so long as the Deferred Compensation Program remains in effect unless all Deferred Stock
Benefits payable with shares of Common Stock under this Plan have been paid or distributed in full or the Deferred Compensation Program is terminated in accordance with its terms on or before such
time. 

 
 

ARTICLE XIX
  DURATION OF PLAN    
    

        No Award may be granted under this Plan 10 years after the Board originally adopted the Plan before its amendment and restatement. Awards granted before
that date shall remain valid in accordance with their terms. 

 
 

ARTICLE XX
  EFFECTIVE DATE OF PLAN    
    

        The Plan, as amended and restated, became effective on January 23, 2003, the date the Board approved it, except that (i) no Restricted Stock,
Restricted Stock Units, SARs or Performance Awards could be granted hereunder; (ii) no shares of Common Stock could be issued for Deferred Stock Benefits; and (iii) the individual award
limit per calendar year was to remain at 750,000 shares of Common Stock, until the Company's stockholders approved the Plan, as amended and restated. The Company's stockholders did approve the Plan,
as amended and restated at the 2003 Annual Meeting of Stockholders. Notwithstanding the foregoing, Options granted before January 23, 2003 shall continue to be governed by the terms of the Plan
as in effect prior to its amendment and restatement and are not eligible to be converted into Deferred Stock Benefits. The Board has again amended the Plan as of October 23, 2003, for which
stockholder approval is not required. 

 
 

ARTICLE XXI
  CLAIMS PROCEDURES    
    

        If a Participant has exercised an Option or a SAR or if shares of Restricted Stock have become vested or Restricted Stock Units or Performance Awards have become
payable, and the Participant has not received the benefits to which the Participant believes he or she is entitled under such Award, then the Participant must submit a written claim for benefits to
the Administrator within 30 days of the date such benefits were due or the claim will be forever barred. 

        If
a claim of a Participant is wholly or partially denied, the Participant or his duly authorized representative may appeal the denial of the claim to the Administrator. Such appeal must
be made at any time within 30 days after the Participant receives written notice from the Company of the denial of the claim. In connection therewith, the Participant or his duly authorized
representative may request a review of the denied claim, may review pertinent documents, and may submit issues and comments in writing. Upon receipt of an appeal, the Administrator shall make a
decision with respect to the appeal 

21

 

and,
not later than 60 days after receipt of such request for review, shall furnish the Participant with the decision on review in writing, including the specific reasons for the decision
written in a manner calculated to be understood by the Participant, as well as specific references to the pertinent provisions of the Plan upon which the decision is based. 

        The
Administrator has the discretionary and final authority under the Plan to determine the validity of a claim. Accordingly, any decision the Administrator makes on a Participant's
appeal will be administratively final. If a Participant disagrees with the Administrator's final decision, the Participant may sue, but only after the claim on appeal has been denied. Any lawsuit must
be filed within 90 days of receipt of the Administrator's final written denial of the Participant's claim or the claim will be forever barred. 

 
 

ARTICLE XXII
  RULES OF CONSTRUCTION    
    

        Headings are given to the articles and sections of this Plan solely as a convenience to facilitate reference. The reference to any statute, regulation, or other
provision of law shall be construed to refer to any amendment to or successor of such provision of law. 

22

QuickLinks

Exhibit 4.4

EARTHLINK, INC. STOCK INCENTIVE PLAN (as amended effective October 23, 2003)

TABLE OF CONTENTS

EARTHLINK, INC. STOCK INCENTIVE PLAN (as amended effective October 23, 2003)

ARTICLE I DEFINITIONS

ARTICLE II PURPOSES

ARTICLE III ADMINISTRATION

ARTICLE IV ELIGIBILITY

ARTICLE V STOCK SUBJECT TO PLAN

ARTICLE VI TERMS AND CONDITIONS OF ALL OPTIONS

ARTICLE VII ADDITIONAL TERMS AND CONDITIONS OF INCENTIVE STOCK OPTIONS

ARTICLE VIII TERMS AND CONDITIONS OF RESTRICTED STOCK

ARTICLE IX TERMS AND CONDITIONS OF RESTRICTED STOCK UNITS

ARTICLE X TERMS AND CONDITIONS OF SARS

ARTICLE XI TERMS AND CONDITIONS OF PERFORMANCE AWARDS

ARTICLE XII ADDITIONAL TERMS AND CONDITIONS APPLICABLE TO ALL AWARDS

ARTICLE XIII DEFERRED BENEFITS

ARTICLE XIV LIMITATION ON BENEFITS

ARTICLE XV ADJUSTMENT UPON CHANGE IN COMMON STOCK

ARTICLE XVI COMPLIANCE WITH LAW AND APPROVAL OF REGULATORY BODIES

ARTICLE XVII GENERAL PROVISIONS

ARTICLE XVIII AMENDMENT

ARTICLE XIX DURATION OF PLAN

ARTICLE XX EFFECTIVE DATE OF PLAN

ARTICLE XXI CLAIMS PROCEDURES

ARTICLE XXII RULES OF CONSTRUCTION

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00060-of-00352.parquet"}]]